SMILES,Name,Conditions,NCT_Number,Phases,Unapproval Probability,Approval Probability
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,_LEUPROLIDE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.094771498664761,0.9052285013352389
CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,_PROGESTERONE,ENDOMETRIAL POLYP,NCT03309709,Phase 3,0.05138942730450007,0.9486105726955
CC(=O)[O-],_ACETATE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.12031503503881595,0.8796849649611838
CC(=O)[O-],_ACETATE,"PROSTATIC NEOPLASMS, CASTRATION-RESISTANT",NCT03431350,Phase 1|Phase 2,0.13639953163634752,0.8636004683636525
CC(=O)[O-],_ACETATE,DEPRESSION,NCT02837432,Early Phase 1,0.13398985990063975,0.8660101400993604
CC(=O)[O-],_ACETATE,BURN,NCT01413620,Phase 1,0.07735354826248829,0.9226464517375116
CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1,_LEUPROLIDE_ACETATE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.25804813418929745,0.7419518658107025
C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,_EXEMESTANE,NON SMALL CELL LUNG CANCER,NCT02666105,Phase 2,0.16656990909557376,0.8334300909044265
C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,_EXEMESTANE,OVARIAN CANCER,NCT04460807,Phase 3,0.02059396952004104,0.9794060304799588
CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,_GOSERELIN,BREAST NEOPLASM,NCT01723774,Phase 2,0.3133598206523169,0.6866401793476828
C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,_FULVESTRANT,NEOPLASMS,NCT02530411,Phase 2,0.16071355902196033,0.8392864409780397
N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,_LETROZOLE,OVARIAN CANCER,NCT03378297,Early Phase 1,0.02299210180457194,0.977007898195428
N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,_LETROZOLE,BRAIN TUMOR,NCT03122197,Early Phase 1,0.2595839063501393,0.7404160936498607
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.1129860300156006,0.8870139699843997
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,"PROSTATIC NEOPLASMS, CASTRATION-RESISTANT",NCT03431350,Phase 1|Phase 2,0.12195776349224592,0.8780422365077541
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,NEWLY DIAGNOSED MULTIPLE MYELOMA,NCT03742297,Phase 3,0.00886850991252241,0.9911314900874776
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,DIFFUSE LARGE B CELL LYMPHOMA,NCT02767674,Phase 3,0.006541421075608187,0.9934585789243918
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,PARKINSON'S DISEASE,NCT04127578,Phase 1|Phase 2,0.2428398615683083,0.7571601384316919
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,METASTATIC PROSTATE CANCER,NCT03764540,Phase 2,0.1032231633225563,0.8967768366774441
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1,_ABIRATERONE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.1832394233927072,0.8167605766072923
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1,_ABIRATERONE,"PROSTATIC NEOPLASMS, CASTRATION-RESISTANT",NCT03431350,Phase 1|Phase 2,0.12946823209528474,0.8705317679047152
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1,_ABIRATERONE,METASTATIC PROSTATE CANCER,NCT04262154,Phase 2,0.2687504879535801,0.7312495120464197
CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C,_CABAZITAXEL,METASTATIC PROSTATE CANCER,NCT03764540,Phase 2,0.1837351059579985,0.8162648940420014
CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC=C(c5cccnc5)[C@@]4(C)CC[C@@H]32)C1,_ABIRATERONE_ACETATE,PROSTATIC NEOPLASMS,NCT03007732,Phase 2,0.3557214634749492,0.6442785365250507
CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC=C(c5cccnc5)[C@@]4(C)CC[C@@H]32)C1,_ABIRATERONE_ACETATE,"PROSTATIC NEOPLASMS, CASTRATION-RESISTANT",NCT03431350,Phase 1|Phase 2,0.2827452966676288,0.7172547033323713
CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,_FLUTAMIDE,PCOS,NCT00930228,Phase 1,0.21566790878027964,0.7843320912197207
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,NEOPLASMS,NCT03693612,Phase 2,0.036343168742237496,0.9636568312577626
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,METASTATIC PROSTATE CANCER,NCT03764540,Phase 2,0.05392835253752665,0.9460716474624736
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,SOFT TISSUE SARCOMA,NCT03449901,Phase 2,0.32670460922205397,0.6732953907779462
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,GASTRIC CANCER,NCT01924819,Phase 2|Phase 3,0.023271448602819957,0.9767285513971804
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT02923258,Phase 2|Phase 3,0.0006901408450704225,0.9993098591549296
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,NEOPLASM METASTASIS,NCT00781612,Phase 2,0.037443230444979485,0.9625567695550206
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,NON-SMALL CELL LUNG CANCER METASTATIC,NCT04154956,Phase 3,0.01638329476989171,0.9836167052301084
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,CASTRATION-RESISTANT PROSTATIC CANCER,NCT04404140,Phase 1,0.010269749968804814,0.9897302500311952
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,"PROSTATIC NEOPLASMS, CASTRATION-RESISTANT",NCT03431350,Phase 1|Phase 2,0.3810097721741997,0.6189902278258004
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,GASTRIC CANCER,NCT04178460,Phase 1,0.2886016723502281,0.7113983276497721
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,PROSTATE CANCER,NCT04194554,Phase 1|Phase 2,0.5025574272257768,0.4974425727742232
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,BREAST CANCER,NCT02826512,Phase 2,0.2706842476495385,0.7293157523504615
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,PANCREATIC CANCER,NCT03601923,Phase 2,0.518972452732227,0.481027547267773
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,LUNG CANCER,NCT03891615,Phase 1,0.518972452732227,0.481027547267773
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,PANCREATIC ADENOCARCINOMA,NCT03404960,Phase 1|Phase 2,0.3508466880656328,0.6491533119343671
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,OVARIAN NEOPLASMS,NCT03955471,Phase 2,0.5772944888976239,0.42270551110237614
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,METASTATIC MELANOMA,NCT03925350,Phase 2,0.518972452732227,0.481027547267773
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,PROSTATIC NEOPLASMS,NCT03834519,Phase 3,0.105529647120871,0.8944703528791292
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,OVARIAN CANCER,NCT03464201,Phase 2,0.13417034745437992,0.8658296525456203
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,METASTATIC PROSTATE CANCER,NCT04179864,Phase 1,0.2904911872606741,0.7095088127393258
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,BREAST CANCER,NCT02955394,Phase 2,0.3725427222039143,0.6274572777960856
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,PROSTATE ADENOCARCINOMA,NCT03829930,Phase 1,0.3312433363188969,0.668756663681103
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.06781083298316748,0.9321891670168324
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,NEOPLASMS,NCT03967223,Phase 2,0.05120666279163882,0.9487933372083612
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,DIFFUSE LARGE B CELL LYMPHOMA,NCT02767674,Phase 3,0.01141421656330778,0.9885857834366922
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,PROSTATE CANCER,NCT03089203,Phase 1,0.10159480325797794,0.8984051967420222
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,PANCREATIC CANCER,NCT04390399,Phase 2,0.08061003238594502,0.9193899676140548
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,METASTATIC RENAL CELL CARCINOMA,NCT02926053,Phase 1,0.06062298185953498,0.939377018140465
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,METASTATIC MELANOMA,NCT03475134,Phase 1,0.06062298185953498,0.939377018140465
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,METASTATIC CASTRATION-RESISTANT PROSTATE CANCER,NCT04227275,Phase 1,0.1803944678689312,0.8196055321310689
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,RHABDOMYOSARCOMA,NCT04388839,Phase 2,0.05407405900864235,0.9459259409913576
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS,NCT02953184,Phase 2,0.019881793177149238,0.9801182068228508
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,HEMATOLOGICAL MALIGNANCY,NCT03344705,Phase 1,0.05708331162970666,0.9429166883702932
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,HEMATOLOGIC NEOPLASMS,NCT01374841,Phase 2,0.06062298185953498,0.939377018140465
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,HEPATOCELLULAR CARCINOMA,NCT04011033,Phase 2|Phase 3,0.003336327116071599,0.9966636728839284
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,RETINOBLASTOMA,NCT02870907,Phase 2,0.009802513597862118,0.990197486402138
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,OSTEOSARCOMA,NCT03063983,Phase 2,0.007942138964611654,0.9920578610353884
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,MULTIPLE SCLEROSIS,NCT03477500,Phase 3,0.012932167783210042,0.98706783221679
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,DIFFUSE LARGE B CELL LYMPHOMA,NCT04214626,Phase 2,0.04088277244842708,0.9591172275515728
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,BREAST CANCER,NCT02897700,Phase 1,0.024619339592974996,0.9753806604070252
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,ACUTE LYMPHOBLASTIC LEUKEMIA PH POSITIVE,NCT01376427,Not Applicable,0.029989073608472437,0.9700109263915274
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,OSTEOSARCOMA,NCT03063983,Phase 2,0.016122091528986734,0.9838779084710134
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,PERIPHERAL T CELL LYMPHOMA,NCT03321890,Phase 2,0.04088277244842708,0.9591172275515728
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,_TACROLIMUS,HEMATOLOGICAL MALIGNANCY,NCT01349101,Phase 2,0.1984683136318441,0.801531686368156
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,_TACROLIMUS,ACUTE MYELOID LEUKEMIA,NCT03467386,Phase 1,0.5252623742201034,0.4747376257798965
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,_TACROLIMUS,LYMPHEDEMA,NCT04390685,Phase 1|Phase 2,0.10315004646429776,0.8968499535357026
CS(=O)(=O)OCCCCOS(C)(=O)=O,_BUSULFAN,LYMPHOMA,NCT03151876,Phase 2,0.1436017096878369,0.8563982903121632
CS(=O)(=O)OCCCCOS(C)(=O)=O,_BUSULFAN,HEMATOLOGICAL MALIGNANCY,NCT01349101,Phase 2,0.2895423550980852,0.7104576449019148
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.15626693627903315,0.8437330637209665
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,NEOPLASMS,NCT03967223,Phase 2,0.10701509388133848,0.8929849061186613
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,METASTATIC RENAL CELL CARCINOMA,NCT02926053,Phase 1,0.04982816317401118,0.9501718368259888
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,METASTATIC MELANOMA,NCT03475134,Phase 1,0.04982816317401118,0.9501718368259888
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,METASTATIC CASTRATION-RESISTANT PROSTATE CANCER,NCT04227275,Phase 1,0.26050148096969794,0.7394985190303021
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,HEMATOLOGICAL MALIGNANCY,NCT03344705,Phase 1,0.07926073326495763,0.920739266735042
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,HEPATOCELLULAR CARCINOMA,NCT02905188,Phase 1,0.24838338402167215,0.7516166159783276
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,PERIPHERAL T CELL LYMPHOMA,NCT04083495,Phase 2,0.24838338402167215,0.7516166159783276
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,GASTRIC CANCER,NCT01924819,Phase 2|Phase 3,0.06256847680695397,0.937431523193046
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT02524275,Phase 2,0.2433757390389992,0.7566242609610012
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,METASTATIC COLORECTAL CANCER,NCT03869892,Phase 3,0.13451585956662046,0.8654841404333795
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,RECTAL CANCER,NCT01716949,Phase 1|Phase 2,0.01198952277174005,0.98801047722826
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,GLIOBLASTOMA,NCT02669173,Phase 1,0.2433757390389992,0.7566242609610012
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.01625714783328416,0.983742852166716
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,STOMACH NEOPLASMS,NCT03675737,Phase 3,0.14117892450574931,0.8588210754942507
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,COLORECTAL CANCER METASTATIC,NCT04245865,Phase 2,0.06256847680695397,0.937431523193046
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,COLON CANCER,NCT01918527,Phase 3,0.0316237791687645,0.9683762208312356
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,BREAST NEOPLASM MALIGNANT FEMALE,NCT04198727,Not Applicable,0.020519782137734286,0.9794802178622658
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,HEAD AND NECK NEOPLASMS,NCT03678649,Phase 2,0.07404840394574225,0.925951596054258
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,OVARIAN CANCER,NCT03936270,Phase 2,0.3411440414972815,0.6588559585027183
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.17890925079419975,0.8210907492057998
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT03389477,Phase 2,0.5388412048398658,0.4611587951601342
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,PROSTATE CANCER,NCT02905318,Phase 2,0.40457333736673057,0.5954266626332694
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,FEMALE BREAST CARCINOMA,NCT02942355,Phase 2,0.5251858649981886,0.4748141350018114
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,LUNG CANCER,NCT03170206,Phase 1|Phase 2,0.41282258666790655,0.5871774133320933
CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,_ANASTROZOLE,FEMALE BREAST CARCINOMA,NCT02942355,Phase 2,0.23180147952387564,0.7681985204761247
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_EVEROLIMUS,SOFT TISSUE SARCOMA,NCT03114527,Phase 2,0.16358969325960251,0.8364103067403974
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_EVEROLIMUS,"CARCINOMA, RENAL CELL",NCT04195750,Phase 3,0.015595412345240206,0.9844045876547598
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_EVEROLIMUS,END STAGE RENAL DISEASE,NCT03413722,,0.2394301498343329,0.7605698501656669
CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,_VINORELBINE,MULTIPLE MYELOMA,NCT03442673,Phase 2,0.0735677289473959,0.9264322710526044
CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,_VINORELBINE,DIFFUSE LARGE B-CELL LYMPHOMA,NCT02733380,Phase 2,0.20219267090075732,0.7978073290992423
CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,_VINORELBINE,RHABDOMYOSARCOMA,NCT04299113,Phase 1,0.4665986593933018,0.5334013406066982
CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,_VINORELBINE,LUNG ADENOCARCINOMA,NCT03891173,Phase 2,0.16534246334718636,0.8346575366528142
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,DIFFUSE LARGE B CELL LYMPHOMA,NCT02767674,Phase 3,0.0163243272249566,0.9836756727750432
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,SOFT TISSUE SARCOMA,NCT03449901,Phase 2,0.33445062047345553,0.6655493795265444
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,MULTIPLE MYELOMA,NCT03442673,Phase 2,0.021748081186854645,0.9782519188131452
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,DIFFUSE LARGE B-CELL LYMPHOMA,NCT04182204,Phase 3,0.05630014729429009,0.94369985270571
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,NK/T CELL LYMPHOMA,NCT04230330,Phase 1,0.09390994423883127,0.9060900557611684
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,BLADDER CANCER,NCT02885974,Phase 1,0.34163939744269795,0.658360602557302
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,LUNG CANCER,NCT02428764,Phase 2,0.06313282756594403,0.9368671724340558
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,PANCREATIC ADENOCARCINOMA,NCT03703089,Phase 1,0.34163939744269795,0.658360602557302
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,METASTATIC BREAST CANCER,NCT03901339,Phase 3,0.05630014729429009,0.94369985270571
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,ADVANCED PANCREATIC CANCER,NCT04098081,Phase 2,0.12340324777785845,0.8765967522221416
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,NON SMALL CELL LUNG CANCER,NCT02477826,Phase 3,0.10218509953901922,0.8978149004609807
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,NEOPLASMS,NCT03693612,Phase 2,0.09977711086357684,0.900222889136423
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,GASTRIC CANCER,NCT03801668,Phase 3,0.05886359983111171,0.9411364001688884
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT04164238,Phase 2,0.019853833125286026,0.9801461668747138
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,NEOPLASM METASTASIS,NCT00781612,Phase 2,0.0818477721573166,0.9181522278426832
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,PANCREATIC CANCER,NCT04054362,Phase 2,0.0637109334184403,0.9362890665815596
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,SMALL CELL LUNG CANCER,NCT04210037,Phase 1|Phase 2,0.0266843714062874,0.9733156285937123
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,BLADDER CANCER,NCT04060459,Phase 2,0.010829712449069374,0.9891702875509306
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,PANCREATIC ADENOCARCINOMA,NCT03703063,Phase 1,0.2357065196815885,0.7642934803184116
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER,NCT04416035,Phase 3,0.06614766368914654,0.9338523363108534
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,ADVANCED NON-SQUAMOUS NSCLC,NCT04325698,Phase 3,0.06614766368914654,0.9338523363108534
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,SQUAMOUS CELL CARCINOMA,NCT03719924,Phase 2,0.04096776411845754,0.9590322358815424
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,GASTROINTESTINAL STROMAL TUMORS,NCT03944304,Phase 2,0.02567337970439309,0.9743266202956068
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1,_EPIRUBICIN,DIFFUSE LARGE B CELL LYMPHOMA,NCT02767674,Phase 3,0.001864511812800891,0.9981354881871992
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1,_EPIRUBICIN,GASTRIC CANCER,NCT01924819,Phase 2|Phase 3,0.011228304047004662,0.9887716959529956
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,PROSTATIC NEOPLASMS,NCT03834519,Phase 3,0.406518588953868,0.5934814110461321
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,NON SMALL CELL LUNG CANCER,NCT03334617,Phase 2,0.35158860174790263,0.6484113982520974
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,OVARIAN CANCER,NCT03378297,Early Phase 1,0.3008469197158022,0.699153080284198
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,BREAST NEOPLASM,NCT03740893,Phase 2,0.3911251882107722,0.6088748117892279
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.2957409395862715,0.7042590604137289
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT03022409,Phase 1,0.4241924935837863,0.5758075064162136
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,PROSTATE CANCER,NCT03810105,Phase 2,0.5346962248863616,0.4653037751136385
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,METASTATIC COLORECTAL CANCER,NCT04456699,Phase 3,0.41630824142978573,0.5836917585702142
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,COLORECTAL CANCER,NCT04166435,Phase 2,0.5656106535593994,0.4343893464406007
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,PROSTATE CANCER METASTATIC,NCT03434158,Phase 2,0.28569965005419296,0.714300349945807
O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,_MITOXANTRONE,DIFFUSE LARGE B-CELL LYMPHOMA,NCT02733380,Phase 2,0.11521223213371044,0.8847877678662897
N=C(N)NCCC[C@H](N)C(=O)O,_ARGININE,SOFT TISSUE SARCOMA,NCT03449901,Phase 2,0.5473658099792668,0.4526341900207331
N=C(N)NCCC[C@H](N)C(=O)O,_ARGININE,GASTRIC CANCER,NCT01704664,Not Applicable,0.18453064800611169,0.8154693519938883
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,NON SMALL CELL LUNG CANCER,NCT03661567,Phase 2,0.08354129323618059,0.9164587067638192
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,PARKINSON'S DISEASE,NCT04127578,Phase 1|Phase 2,0.44404499245689294,0.5559550075431071
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,PNEUMONIA,NCT03852537,Phase 2,0.193723988105756,0.8062760118942442
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,ACUTE LYMPHOBLASTIC LEUKEMIA,NCT03913559,Phase 2,0.45008670381567617,0.5499132961843238
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,MULTIPLE MYELOMA,NCT03110822,Phase 1,0.44404499245689294,0.5559550075431071
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,IRREVERSIBLE PULPITIS,NCT04157036,Phase 3,0.3987525829925092,0.6012474170074907
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,PANCREATIC CANCER,NCT04048278,Early Phase 1,0.0039465348161464905,0.9960534651838536
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,"PAIN, CHRONIC",NCT02983682,Phase 3,0.12425216142130124,0.8757478385786988
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,CONTRACEPTION,NCT02799641,Not Applicable,0.01318020315785503,0.9868197968421448
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,SCAR,NCT02234193,Early Phase 1,0.00775679920183856,0.9922432007981616
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,POST-DURAL PUNCTURE HEADACHE,NCT03560349,Phase 2,0.020068356990783284,0.9799316430092168
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,METASTATIC MELANOMA,NCT03817125,Phase 1,0.2288619146226568,0.7711380853773433
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,_VANCOMYCIN,ULCERATIVE COLITIS,NCT03759041,Phase 2,0.23633600018654136,0.7636639998134587
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,LEUKEMIA,NCT04547049,Phase 3,0.12440654699223255,0.8755934530077676
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,HEMATOLOGICAL MALIGNANCY,NCT01349101,Phase 2,0.3705974629424823,0.6294025370575175
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,ACUTE MYELOID LEUKEMIA,NCT02782546,Phase 2,0.5411642106392373,0.4588357893607628
S=P(N1CC1)(N1CC1)N1CC1,_THIOTEPA,BREAST CANCER,NCT01646034,Phase 3,0.14552998976924106,0.8544700102307591
S=P(N1CC1)(N1CC1)N1CC1,_THIOTEPA,LEUKEMIA,NCT03342196,Phase 2,0.40421349089929776,0.5957865091007022
S=P(N1CC1)(N1CC1)N1CC1,_THIOTEPA,RETINOBLASTOMA,NCT02870907,Phase 2,0.17359961144957556,0.8264003885504246
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,PARKINSON'S DISEASE,NCT04127578,Phase 1|Phase 2,0.2555801848596339,0.7444198151403661
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,BETA-THALASSEMIA,NCT03877809,Phase 2,0.011923274111378772,0.9880767258886212
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,ISCHEMIC HEART DISEASE,NCT03600961,,0.06806578984440305,0.9319342101555971
Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,_CLADRIBINE,LEUKEMIA,NCT01515527,Phase 2,0.2978872153120196,0.7021127846879804
Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,_CLADRIBINE,ACUTE LYMPHOBLASTIC LEUKEMIA,NCT03318419,Phase 2,0.15297570502608354,0.8470242949739163
Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,_CLADRIBINE,LYMPHOMA,NCT03151876,Phase 2,0.1043631302150241,0.8956368697849758
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,_CYTARABINE,DIFFUSE LARGE B CELL LYMPHOMA,NCT03072771,Phase 1,0.3982197553456015,0.6017802446543985
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,_CYTARABINE,MYELODYSPLASTIC SYNDROME,NCT03412266,Phase 2,0.04291575356938514,0.9570842464306148
CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O,_ELTROMBOPAG,ACUTE MYELOID LEUKEMIA,NCT03603795,Phase 2,0.39719306008373,0.6028069399162699
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,NEWLY DIAGNOSED MULTIPLE MYELOMA,NCT03742297,Phase 3,0.13244853772004225,0.8675514622799576
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,DIFFUSE LARGE B CELL LYMPHOMA,NCT03072771,Phase 1,0.4660551934747916,0.5339448065252084
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,METASTATIC MELANOMA,NCT01920516,,0.2467306576480351,0.7532693423519651
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,ACUTE MYELOID LEUKEMIA,NCT02771197,Phase 2,0.4660551934747916,0.5339448065252084
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCCCCN2C(=O)[CH]CC2=O)C(C)C)cc1)C(C)C,_VEDOTIN,NON SMALL CELL LUNG CANCER,NCT03539536,Phase 2,0.30603567965572964,0.6939643203442702
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCCCCN2C(=O)[CH]CC2=O)C(C)C)cc1)C(C)C,_VEDOTIN,DIFFUSE LARGE B-CELL LYMPHOMA,NCT04182204,Phase 3,0.4949637995909795,0.5050362004090205
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,_VINCRISTINE,ACUTE LYMPHOBLASTIC LEUKEMIA PH POSITIVE,NCT01376427,Not Applicable,0.09219811290718477,0.9078018870928152
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,_VINCRISTINE,RHABDOMYOSARCOMA,NCT04388839,Phase 2,0.3376279297967449,0.6623720702032552
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,_LEUCOVORIN,GASTRIC CANCER,NCT01924819,Phase 2|Phase 3,0.14156845440668822,0.8584315455933119
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,_LEUCOVORIN,PANCREATIC CANCER,NCT04390399,Phase 2,0.3446857952567017,0.6553142047432984
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,_LEUCOVORIN,RECTAL CANCER,NCT03000374,Phase 2,0.07104281820313661,0.9289571817968632
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,_LEUCOVORIN,PANCREATIC ADENOCARCINOMA,NCT03193190,Phase 1|Phase 2,0.1874007693250856,0.8125992306749146
Nc1nc2c(c(=O)[nH]1)N(C=O)C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2,_LEUCOVORIN,COLORECTAL CANCER METASTATIC,NCT03164655,Phase 2,0.14156845440668822,0.8584315455933119
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,DEPRESSION,NCT02837432,Early Phase 1,0.19572096383691348,0.8042790361630865
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,PROSTATE CANCER,NCT00859781,Phase 2,0.3627877142010552,0.6372122857989447
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,SEPSIS,NCT04160676,Not Applicable,0.002187676530454741,0.9978123234695454
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,CARDIOGENIC SHOCK,NCT03773822,Phase 3,0.002187676530454741,0.9978123234695454
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,_ETOPOSIDE,NON SMALL CELL LUNG CANCER,NCT03840902,Phase 2,0.15480316051548434,0.8451968394845154
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,_ETOPOSIDE,DIFFUSE LARGE B CELL LYMPHOMA,NCT03072771,Phase 1,0.3782579131511368,0.6217420868488632
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,_ETOPOSIDE,OSTEOSARCOMA,NCT04154189,Phase 2,0.20396626831564213,0.7960337316843576
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISOLONE,PROSTATIC NEOPLASMS,NCT04034095,,0.042724642487581656,0.9572753575124182
Nc1nc(O)c2c(n1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1)N2C=O.[Ca+2],_LEUCOVORIN_CALCIUM,METASTATIC COLORECTAL CANCER,NCT04097444,Phase 2,0.3786676200100136,0.6213323799899862
CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O,_IDARUBICIN,HEPATOCELLULAR CARCINOMA,NCT04178642,Phase 2,0.038901365120316486,0.9610986348796834
CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O,_IDARUBICIN,"CARCINOMA, HEPATOCELLULAR",NCT03727633,Phase 2,0.1419738476378895,0.8580261523621106
CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O,_IDARUBICIN,ACUTE MYELOBLASTIC LEUKEMIA,NCT01296178,Not Applicable,0.016037666173975524,0.9839623338260244
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,PROSTATE CANCER,NCT03513211,Phase 1|Phase 2,0.2521200623375521,0.7478799376624481
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,MULTIPLE MYELOMA,NCT04163107,Phase 1,0.2792621375290211,0.7207378624709789
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,MULTIPLE SCLEROSIS,NCT03109288,Phase 1|Phase 2,0.4887791656910484,0.5112208343089516
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,GASTROINTESTINAL CANCER,NCT04214418,Phase 1|Phase 2,0.4400500967036754,0.5599499032963245
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,PROSTATE CANCER RECURRENT,NCT04011410,Phase 2,0.5231197490474444,0.4768802509525555
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,ACUTE LYMPHOBLASTIC LEUKEMIA,NCT03913559,Phase 2,0.3649859838601747,0.6350140161398252
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,MULTIPLE MYELOMA,NCT04268498,Phase 2,0.07897922005477732,0.9210207799452226
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04165096,Phase 2,0.10821421379354186,0.8917857862064583
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,MULTIPLE SCLEROSIS,NCT03824938,Phase 1|Phase 2,0.2566053371026381,0.7433946628973618
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,ANALGESIA,NCT03955211,Phase 2,0.35158132639339595,0.6484186736066039
CN(C)CCOC(c1ccccc1)c1ccccc1,_DIPHENHYDRAMINE,ACUTE LYMPHOBLASTIC LEUKEMIA,NCT03913559,Phase 2,0.2674393125547502,0.7325606874452497
CN(C)CCOC(c1ccccc1)c1ccccc1,_DIPHENHYDRAMINE,MULTIPLE MYELOMA,NCT04268498,Phase 2,0.051616300704171135,0.9483836992958288
CN(C)CCOC(c1ccccc1)c1ccccc1,_DIPHENHYDRAMINE,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04165096,Phase 2,0.16135868982769247,0.8386413101723074
O=P1(NCCCl)OCCCN1CCCl,_IFOSFAMIDE,DIFFUSE LARGE B CELL LYMPHOMA,NCT03736616,Phase 2,0.21613175237629986,0.7838682476237002
O=P1(NCCCl)OCCCN1CCCl,_IFOSFAMIDE,OSTEOSARCOMA,NCT04154189,Phase 2,0.13405350112233275,0.8659464988776672
Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,_SELUMETINIB,NON SMALL CELL LUNG CANCER,NCT03392246,Phase 2,0.7766545007407943,0.22334549925920552
Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,_SELUMETINIB,NEUROFIBROMATOSIS TYPE 1,NCT04495127,Phase 1,0.9303162894359284,0.06968371056407173
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O,_OCTREOTIDE,GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMOR,NCT03972488,Phase 3,0.20729031163947365,0.7927096883605261
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,ACUTE LYMPHOBLASTIC LEUKEMIA PH POSITIVE,NCT01376427,Not Applicable,0.002830585022581661,0.9971694149774184
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,DIFFUSE LARGE B-CELL LYMPHOMA,NCT02733380,Phase 2,0.01900018319092902,0.9809998168090708
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,NK/T CELL LYMPHOMA,NCT04230330,Phase 1,0.04318099287943044,0.9568190071205696
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,METASTATIC COLORECTAL CANCER,NCT03626922,Phase 1,0.21703986832454716,0.7829601316754531
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,LYMPHOMA,NCT02436707,Phase 2,0.062448545542348625,0.9375514544576514
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,WALDENSTRÃ–M MACROGLOBULINEMIA,NCT04463953,Phase 2,0.01900018319092902,0.9809998168090708
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_DEXAMETHASONE,CUSHING DISEASE,NCT03974789,,0.03650884950091976,0.9634911504990802
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,_DEXTROSE,OSTEO ARTHRITIS OF THE KNEES,NCT03400631,Not Applicable,0.1013479319352202,0.8986520680647796
C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O,_SOMATOSTATIN,HEPATOCELLULAR CARCINOMA,NCT02799212,Phase 3,0.1507754153410187,0.8492245846589812
C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,_CABERGOLINE,ENDOMETRIOSIS,NCT03928288,Phase 2,0.2526677758452025,0.7473322241547977
CNCC[C@@H](Oc1ccccc1C)c1ccccc1,_ATOMOXETINE,"OBESITY, MORBID",NCT03460210,,0.17748746148265596,0.8225125385173437
CC(C)NCC(O)COc1cccc2ccccc12,_PROPRANOLOL,GASTRIC CANCER,NCT04005365,Phase 2,0.15542368744651502,0.8445763125534851
CC(C)NCC(O)COc1cccc2ccccc12,_PROPRANOLOL,COLORECTAL NEOPLASMS,NCT03919461,Phase 2,0.01548786173105824,0.984512138268942
CC(C)NCC(O)COc1cccc2ccccc12,_PROPRANOLOL,POSTPARTUM HAEMORRHAGE,NCT03434444,Not Applicable,0.1064321708610148,0.8935678291389851
CC(=O)Nc1nnc(S(N)(=O)=O)s1,_ACETAZOLAMIDE,SMALL CELL LUNG CANCER,NCT03467360,Phase 1,0.5265430345905648,0.4734569654094353
CC12CC3CC(C)(C1)CC(N)(C3)C2,_MEMANTINE,CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY,NCT03709888,,0.2184893500097524,0.7815106499902477
CC12CC3CC(C)(C1)CC(N)(C3)C2,_MEMANTINE,COGNITION DISORDERS,NCT03342443,Phase 2|Phase 3,0.02891052728775244,0.9710894727122475
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,MULTIPLE SCLEROSIS,NCT04035889,Not Applicable,0.2105385310873088,0.7894614689126912
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,OSTEOPENIA,NCT04233112,Early Phase 1,0.2764232005828675,0.7235767994171323
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,MIGRAINE DISORDERS,NCT03597529,Phase 2,0.19527426971615186,0.8047257302838483
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,METASTATIC COLORECTAL CANCER,NCT03626922,Phase 1,0.3694682453444243,0.6305317546555758
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,DELIRIUM,NCT04456985,Not Applicable,0.07896448256018798,0.9210355174398124
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,ANEMIA,NCT04404751,Not Applicable,0.059984225926950664,0.9400157740730491
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,MUCOSITIS,NCT03581773,Phase 2,0.0670473591232251,0.9329526408767752
O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12,_BIOTIN,ANEMIA,NCT02757898,Phase 1,0.7323607435084688,0.2676392564915313
C[N+](C)(C)CCO,_CHOLINE,PROSTATE ADENOCARCINOMA,NCT03404648,Phase 3,0.6109629849436955,0.3890370150563047
O=C([O-])C[N+]12CC[N+]3(CC(=O)[O-])CC[N+]4([C@@H](CO)[C@@H](O)CO)CC[N+](CC(=O)[O-])(CC1)[Gd-]234,_GADOBUTROL,PROSTATE ADENOCARCINOMA,NCT03404648,Phase 3,0.5549331122443188,0.4450668877556812
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,OVARIAN CANCER,NCT03924882,Phase 2,0.0964758821507296,0.9035241178492704
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,SOFT TISSUE SARCOMA,NCT03890068,Phase 2,0.12819871366415522,0.8718012863358449
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,GLIOBLASTOMA,NCT04119674,Phase 1|Phase 2,0.028936151558306436,0.9710638484416936
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,LUNG CANCER,NCT03983928,Phase 1|Phase 2,0.13703213379136345,0.8629678662086365
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,HEPATOCELLULAR CARCINOMA,NCT03945799,Phase 1|Phase 2,0.028936151558306436,0.9710638484416936
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,GASTROINTESTINAL STROMAL TUMORS,NCT04106024,Phase 2,0.13703213379136345,0.8629678662086365
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,THYROID CANCER,NCT04309136,Phase 2,0.0989639379923968,0.9010360620076034
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,"CARCINOMA, HEPATOCELLULAR",NCT04066543,Phase 2,0.09943986403958008,0.9005601359604198
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,LUNG NEOPLASMS,NCT03940404,,0.19349049820625328,0.8065095017937469
NC(=O)CC[C@H](N)C(=O)O,_GLUTAMINE,BURN,NCT00985205,Phase 3,0.28017748854591745,0.7198225114540828
NC(=O)CC[C@H](N)C(=O)O,_GLUTAMINE,GASTRIC CANCER,NCT01704664,Not Applicable,0.1270961062587741,0.8729038937412259
NC(=O)CC[C@H](N)C(=O)O,_L-GLUTAMINE,BURN,NCT00985205,Phase 3,0.28017748854591745,0.7198225114540828
NC(=O)CC[C@H](N)C(=O)O,_L-GLUTAMINE,GASTRIC CANCER,NCT01704664,Not Applicable,0.1270961062587741,0.8729038937412259
CNC[C@H](O)c1cccc(O)c1,_PHENYLEPHRINE,"STRESS DISORDERS, POST-TRAUMATIC",NCT02560805,Phase 2,0.19309959374042487,0.8069004062595753
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,_ASCORBIC_ACID,BLADDER CANCER,NCT04046094,Phase 1|Phase 2,0.6794954047515648,0.3205045952484357
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,_ASCORBIC_ACID,SEPSIS,NCT04160676,Not Applicable,0.17712211670851338,0.8228778832914861
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,_ASCORBIC_ACID,COLORECTAL NEOPLASMS,NCT02969681,Phase 3,0.16799297880134442,0.8320070211986551
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,_ASCORBIC_ACID,GLIOBLASTOMA MULTIFORME,NCT02344355,Phase 2,0.7350599344958577,0.26494006550414234
Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,_AZACITIDINE,PANCREATIC CANCER,NCT01845805,Phase 2,0.3685439200489819,0.6314560799510182
Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,_AZACITIDINE,PERIPHERAL T CELL LYMPHOMA,NCT04480125,Phase 2,0.2649848134262231,0.7350151865737767
Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,_AZACITIDINE,HEAD AND NECK CANCER,NCT03019003,Phase 1|Phase 2,0.575305888297001,0.4246941117029992
Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,_PAZOPANIB,GLIOBLASTOMA MULTIFORME,NCT02331498,Phase 1|Phase 2,0.3459773316130538,0.6540226683869459
Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,_PAZOPANIB,KIDNEY CANCER,NCT03571438,Not Applicable,0.20853886761397747,0.7914611323860226
Cn1nnc2c(C(N)=O)ncn2c1=O,_TEMOZOLOMIDE,SMALL CELL LUNG CANCER,NCT04400188,Phase 1|Phase 2,0.1290208434883202,0.8709791565116798
Cn1nnc2c(C(N)=O)ncn2c1=O,_TEMOZOLOMIDE,METASTATIC COLORECTAL CANCER,NCT03832621,Phase 2,0.20212718706912092,0.7978728129308793
Cn1nnc2c(C(N)=O)ncn2c1=O,_TEMOZOLOMIDE,COLORECTAL CANCER,NCT04166435,Phase 2,0.4358448962046975,0.5641551037953024
Cn1nnc2c(C(N)=O)ncn2c1=O,_TEMOZOLOMIDE,GLIOMA,NCT03257618,Not Applicable,0.20212718706912092,0.7978728129308793
Cn1nnc2c(C(N)=O)ncn2c1=O,_TEMOZOLOMIDE,GLIOBLASTOMA MULTIFORME,NCT02344355,Phase 2,0.4376626177154159,0.5623373822845842
Cn1nnc2c(C(N)=O)ncn2c1=O,_TEMOZOLOMIDE,PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA,NCT03495960,Phase 2,0.06400673528413914,0.9359932647158608
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O,_HYDROXYCHLOROQUINE_SULFATE,PROSTATE CANCER RECURRENT,NCT04011410,Phase 2,0.7619272897451581,0.2380727102548416
Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,_LENALIDOMIDE,DIFFUSE LARGE B CELL LYMPHOMA,NCT04214626,Phase 2,0.16208522126346125,0.8379147787365391
Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,_LENALIDOMIDE,MANTLE CELL LYMPHOMA,NCT04109872,,0.1519828099635556,0.8480171900364444
Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,_LENALIDOMIDE,DIFFUSE LARGE B-CELL LYMPHOMA,NCT04404283,Phase 3,0.2575385390344188,0.7424614609655812
Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,_LENALIDOMIDE,NON HODGKIN LYMPHOMA,NCT02180711,Phase 1|Phase 2,0.3970272001875696,0.6029727998124301
Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,_POMALIDOMIDE,RELAPSED OR REFRACTORY MULTIPLE MYELOMA,NCT04191616,Phase 2,0.8100336614480572,0.1899663385519432
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,BREAST CANCER,NCT02790580,Phase 2,0.11067878141793587,0.8893212185820638
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,OSTEOSARCOMA,NCT03900793,Phase 1,0.5178591194025971,0.4821408805974029
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,STOMACH NEOPLASMS,NCT03170180,Phase 2,0.09829311560663836,0.9017068843933616
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,GASTROINTESTINAL STROMAL TUMORS,NCT03673501,Phase 3,0.2311094346159271,0.7688905653840729
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,KIDNEY CANCER,NCT03571438,Not Applicable,0.0542902483585896,0.9457097516414104
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,RENAL CELL CARCINOMA,NCT02919371,Phase 1|Phase 2,0.06890001570931888,0.9310999842906809
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,PANCREATIC NEUROENDOCRINE TUMORS,NCT02282059,,0.07937257238253771,0.9206274276174624
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_TEMSIROLIMUS,KIDNEY CANCER,NCT03571438,Not Applicable,0.15298031654758407,0.847019683452416
OC[C@H]1O[C@@H](O)[C@H](F)[C@@H](O)[C@@H]1O,_FLUDEOXYGLUCOSE,GLIOBLASTOMA,NCT04315584,Early Phase 1,0.9987590217056584,0.0012409782943417216
N[C@@H](Cc1ccc(O)cc1)C(=O)O,_TYROSINE,"CARCINOMA, NON-SMALL-CELL LUNG",NCT03799094,Phase 1|Phase 2,0.4471185881196657,0.5528814118803341
N[C@@H](Cc1ccc(O)cc1)C(=O)O,_TYROSINE,NSCLC,NCT04318938,Phase 2,0.5066791035848115,0.4933208964151884
N[C@@H](Cc1ccc(O)cc1)C(=O)O,_TYROSINE,THYROID CANCER,NCT04521348,Phase 2,0.5666377336779544,0.4333622663220457
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT03153982,Phase 2,0.5406200478796621,0.4593799521203378
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,LEUKEMIA,NCT02723994,Phase 2,0.4061260667224951,0.5938739332775048
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,MULTIPLE MYELOMA,NCT03110822,Phase 1,0.5130561741163586,0.4869438258836414
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,LYMPHOMA,NCT02974647,Phase 2,0.393387853790659,0.6066121462093409
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,HODGKIN LYMPHOMA,NCT03681561,Phase 1|Phase 2,0.5406200478796621,0.4593799521203378
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,GASTRIC CANCER,NCT04358341,Phase 2,0.002412855590777614,0.9975871444092224
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS,NCT02953184,Phase 2,0.007274899825739104,0.9927251001742609
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,RETINOBLASTOMA,NCT01783535,Phase 2,0.2201896125676954,0.7798103874323047
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,METASTATIC BREAST CANCER,NCT04159818,Phase 2,0.038657107537571116,0.9613428924624291
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,BASAL CELL CARCINOMA,NCT03646188,Phase 1,0.3236890317905573,0.6763109682094428
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,_DOXORUBICIN_HYDROCHLORIDE,OVARIAN CANCER,NCT04337632,Phase 3,0.06972504838319532,0.9302749516168048
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,_DOXORUBICIN_HYDROCHLORIDE,MANTLE CELL LYMPHOMA,NCT03710772,Phase 2,0.6477318684425779,0.3522681315574221
O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,_ZOLEDRONIC_ACID,"CARCINOMA, NON-SMALL-CELL LUNG",NCT03958565,,0.3072402459743742,0.6927597540256261
COC(=O)C(c1ccccc1)C1CCCCN1,_METHYLPHENIDATE,"OBESITY, MORBID",NCT03440190,,0.10575655275210882,0.8942434472478911
COC(=O)C(c1ccccc1)C1CCCCN1,_METHYLPHENIDATE,ANXIETY,NCT02153944,Not Applicable,0.1535149495806853,0.8464850504193145
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,_AFATINIB,LUNG CANCER,NCT01553942,Phase 2,0.3321054939421204,0.6678945060578795
O=C([O-])[O-].[Ca+2],_CALCIUM_CARBONATE,LIVER CIRRHOSIS,NCT02642874,Phase 3,0.2404896781090775,0.7595103218909226
O=C([O-])[O-].[Ca+2],_CALCIUM_CARBONATE,OSTEOPOROSIS,NCT04550078,Not Applicable,0.4639521285409685,0.5360478714590314
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O,_CALCIFEDIOL,MYOCARDIAL INFARCTION,NCT02548364,Phase 3,0.05643666938107124,0.9435633306189288
CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,_LUTEIN,PROSTATE CANCER,NCT04136353,Phase 3,0.6541613372369528,0.3458386627630473
CC1=C[C@H](O)CC(C)(C)[C@H]1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,_LUTEIN,GLAUCOMA,NCT03959592,Phase 1|Phase 2,0.5560094141109492,0.4439905858890508
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,PROSTATE CANCER,NCT03769766,Phase 3,0.35146187909697,0.6485381209030298
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,BREAST CANCER,NCT03980509,Phase 1,0.5469970610372653,0.4530029389627346
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,ULCERATIVE COLITIS,NCT02277223,Phase 3,0.15065171170489852,0.8493482882951016
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,"PAIN, POSTOPERATIVE",NCT04280263,Not Applicable,0.15077117377614765,0.8492288262238523
Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,_VITAMIN_E,BREAST CANCER,NCT04463459,Not Applicable,0.5359007045637321,0.4640992954362682
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,_CHOLECALCIFEROL,END STAGE RENAL DISEASE,NCT04145492,Phase 2|Phase 3,0.08209954501515376,0.9179004549848462
CN(C)C(=N)NC(=N)N,_METFORMIN,NON SMALL CELL LUNG CANCER,NCT03874000,Phase 2,0.31015879414570635,0.6898412058542935
CN(C)C(=N)NC(=N)N,_METFORMIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.17408387491685776,0.8259161250831423
CN(C)C(=N)NC(=N)N,_METFORMIN,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT02949700,Phase 1|Phase 2,0.5562677586005614,0.4437322413994387
CN(C)C(=N)NC(=N)N,_METFORMIN,BREAST CANCER,NCT04559308,Phase 2,0.026874433260699188,0.9731255667393008
CN(C)C(=N)NC(=N)N,_METFORMIN,FAMILIAL ADENOMATOUS POLYPOSIS,NCT01725490,Phase 2,0.03606202020483587,0.9639379797951642
CN(C)C(=N)NC(=N)N,_METFORMIN,GLIOBLASTOMA,NCT03151772,Early Phase 1,0.09952837897859874,0.9004716210214013
CN(C)C(=N)NC(=N)N,_METFORMIN,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04170959,Phase 2,0.03554892402699281,0.9644510759730074
CN(C)C(=N)NC(=N)N,_METFORMIN,COLON CANCER,NCT03359681,Phase 2,0.03554892402699281,0.9644510759730074
CN(C)C(=N)NC(=N)N,_METFORMIN,GLIOBLASTOMA MULTIFORME,NCT02780024,Phase 2,0.3914891108946555,0.6085108891053445
CN(C)C(=N)NC(=N)N,_METFORMIN,HEART FAILURE,NCT03331861,Phase 2,0.06573100613319101,0.9342689938668092
CN(C)C(=N)NC(=N)N,_METFORMIN,RHEUMATOID ARTHRITIS,NCT04068246,Early Phase 1,0.03554892402699281,0.9644510759730074
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,NEOPLASMS,NCT02964013,Phase 1,0.14507563924803285,0.8549243607519671
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,NON-SMALL CELL LUNG CANCER METASTATIC,NCT04163432,Phase 2,0.2618849917535677,0.7381150082464322
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,METASTATIC COLORECTAL CANCER,NCT03626922,Phase 1,0.32068669923791016,0.6793133007620898
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,COLORECTAL CANCER,NCT02588781,Phase 2,0.09078000976559462,0.9092199902344056
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,LUNG CANCER,NCT01553942,Phase 2,0.38358171284689135,0.6164182871531086
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,LUNG NEOPLASMS,NCT03380468,Phase 2|Phase 3,0.014317516037086394,0.9856824839629136
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,NON-SQUAMOUS NSCLC,NCT03802240,Phase 3,0.1158762478030923,0.8841237521969076
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,CARCINOMA|NON-SMALL-CELL LUNG,NCT03952403,Phase 3,0.1158762478030923,0.8841237521969076
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.13322180269598696,0.8667781973040131
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,COLORECTAL CANCER,NCT03957902,Phase 2,0.060051781055804485,0.9399482189441956
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,SEPSIS,NCT01784159,Phase 2,0.0042312770575822466,0.9957687229424178
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,MULTIPLE SCLEROSIS,NCT03824938,Phase 1|Phase 2,0.14916484067657515,0.8508351593234249
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,COLON CANCER,NCT03464305,Phase 3,0.0042312770575822466,0.9957687229424178
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,HEAD AND NECK CANCER,NCT03245489,Phase 1,0.06571286483791007,0.9342871351620902
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,"CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE",NCT04160546,Phase 2,0.2353285021928087,0.7646714978071913
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,OVARIAN CANCER,NCT03378297,Early Phase 1,0.13322180269598696,0.8667781973040131
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,COLORECTAL CANCER,NCT03957902,Phase 2,0.060051781055804485,0.9399482189441956
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,SEPSIS,NCT01784159,Phase 2,0.0042312770575822466,0.9957687229424178
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,MULTIPLE SCLEROSIS,NCT03824938,Phase 1|Phase 2,0.14916484067657515,0.8508351593234249
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,COLON CANCER,NCT03464305,Phase 3,0.0042312770575822466,0.9957687229424178
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,HEAD AND NECK CANCER,NCT03245489,Phase 1,0.06571286483791007,0.9342871351620902
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,"CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE",NCT04160546,Phase 2,0.2353285021928087,0.7646714978071913
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,_MORPHINE,NEUROPATHIC PAIN,NCT01914042,Phase 2,0.0036969102914296494,0.9963030897085704
NC(N)=O,_UREA,HELICOBACTER PYLORI INFECTION,NCT04233684,Not Applicable,0.5860739935107461,0.41392600648925415
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC,_ICOSAPENT_ETHYL,COLON CANCER,NCT03661047,Phase 2,0.23450394165230365,0.7654960583476964
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,_VITAMIN_A,EFFICACY AND SAFETY,NCT03779776,Not Applicable,0.12670692537895134,0.8732930746210487
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,_PENTOXIFYLLINE,ACUTE LYMPHOBLASTIC LEUKEMIA,NCT02451774,Phase 2|Phase 3,0.1734335493413549,0.8265664506586452
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,_PENTOXIFYLLINE,ERECTILE DYSFUNCTION|PROSTATE CANCER,NCT03406169,Phase 3,0.4461359835272131,0.5538640164727868
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,BREAST CANCER,NCT02958852,Phase 2,0.12654341132026528,0.8734565886797349
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,COLORECTAL CANCER,NCT04151355,Not Applicable,0.12157421507334355,0.8784257849266566
CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,_VALSARTAN,"OBESITY, MORBID",NCT03535376,,0.25104211654613856,0.7489578834538614
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,GASTRIC CANCER,NCT04379596,Phase 2,0.28680095191299604,0.713199048087004
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT03340896,Phase 3,0.12393742624731476,0.8760625737526848
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,BREAST CANCER,NCT02897700,Phase 1,0.1502697693981278,0.8497302306018717
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,RECTAL CANCER,NCT03299660,Phase 2,0.24955151138895454,0.7504484886110453
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,PANCREATIC ADENOCARCINOMA,NCT03193190,Phase 1|Phase 2,0.2705280573107955,0.7294719426892045
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,COLORECTAL CANCER METASTATIC,NCT04245865,Phase 2,0.12393742624731476,0.8760625737526848
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,_IRINOTECAN,GASTRIC CANCER,NCT04358341,Phase 2,0.05106624301780615,0.9489337569821938
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,_IRINOTECAN,PANCREATIC CANCER,NCT04390399,Phase 2,0.3309465981405959,0.6690534018594042
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,_IRINOTECAN,PANCREATIC ADENOCARCINOMA,NCT03665441,Phase 3,0.14818881903734318,0.8518111809626567
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,_IRINOTECAN,COLORECTAL CANCER METASTATIC,NCT03164655,Phase 2,0.08163537436686054,0.9183646256331396
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,_IRINOTECAN,ADVANCED COLORECTAL CANCER,NCT04337879,Phase 1|Phase 2,0.07210962241049018,0.9278903775895097
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O.O.O,_IRINOTECAN_HYDROCHLORIDE,SMALL CELL LUNG CANCER,NCT04381910,Phase 2,0.40126306552275137,0.5987369344772486
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O.O.O,_IRINOTECAN_HYDROCHLORIDE,METASTATIC COLORECTAL CANCER,NCT04097444,Phase 2,0.4761837208278973,0.5238162791721028
COCCc1ccc(OCC(O)CNC(C)C)cc1,_METOPROLOL,"OBESITY, MORBID",NCT03519906,,0.1971780002805565,0.8028219997194437
C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,_DIGOXIN,ACTINIC KERATOSIS,NCT03684772,Phase 2,0.4552620295711916,0.5447379704288084
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,MULTIPLE MYELOMA,NCT04268498,Phase 2,0.24061075051611056,0.7593892494838896
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,RHEUMATOID ARTHRITIS,NCT03770923,Phase 3,0.24061075051611056,0.7593892494838896
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,PAIN,NCT02793375,Phase 3,0.31258006447474274,0.6874199355252572
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,BREAST CANCER,NCT04172220,Not Applicable,0.026465166294538083,0.973534833705462
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,"HEPATITIS B, CHRONIC",NCT02952924,Phase 1,0.1189105858128418,0.8810894141871582
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,POST TRAUMATIC STRESS DISORDER,NCT02727998,Phase 2,0.08332298188042023,0.9166770181195798
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,FATIGUE,NCT04141696,Phase 1|Phase 2,0.21430188141191028,0.7856981185880898
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,_ROSUVASTATIN,OVARIAN CANCER,NCT03532139,Phase 2,0.4895759301718188,0.5104240698281812
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,_ROSUVASTATIN,RECTAL CANCER,NCT02569645,Phase 2,0.3305837537660057,0.6694162462339945
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,_SIMVASTATIN,LYMPHOMA,NCT04514029,Early Phase 1,0.6637192009130816,0.3362807990869186
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,_SIMVASTATIN,DILATED CARDIOMYOPATHY,NCT03775070,Phase 2,0.3611199370220183,0.6388800629779818
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,"OBESITY, MORBID",NCT03440177,,0.21648268004428164,0.7835173199557184
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,MYOCARDIAL INFARCTION,NCT03715998,Phase 2,0.15857030615188747,0.8414296938481126
CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,_BUPROPION,WILSON DISEASE,NCT04526210,Phase 1,0.11514471508308999,0.8848552849169101
CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12,_PSILOCYBIN,POST-TRAUMATIC HEADACHE,NCT03806985,Phase 1,0.5839689067625082,0.4160310932374919
CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1.Cl,_BUPROPION_HYDROCHLORIDE,WILSON DISEASE,NCT04526210,Phase 1,0.5212144962967122,0.4787855037032877
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,BREAST CANCER,NCT03109990,Not Applicable,0.005066519574395707,0.9949334804256044
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,POST-DURAL PUNCTURE HEADACHE,NCT04327726,Not Applicable,0.008144409021631887,0.991855590978368
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,ANALGESIA,NCT04442906,Not Applicable,0.004484788993384586,0.9955152110066154
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,PHEOCHROMOCYTOMA,NCT04320589,Phase 2,0.007562678440620767,0.9924373215593794
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,ABDOMINAL CANCER,NCT03762785,Phase 1|Phase 2,0.004484788993384586,0.9955152110066154
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,_BORTEZOMIB,DIFFUSE LARGE B CELL LYMPHOMA,NCT03129828,Phase 1|Phase 2,0.21394792052892544,0.7860520794710745
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,_BORTEZOMIB,HEMATOLOGICAL MALIGNANCY,NCT03850366,Phase 2,0.5416252080066516,0.4583747919933485
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,_BORTEZOMIB,ACUTE MYELOID LEUKEMIA,NCT04173585,Phase 2,0.14084894412663507,0.8591510558733649
CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21,_VALGANCICLOVIR,GLIOBLASTOMA MULTIFORME,NCT04116411,Phase 2,0.16211565010617182,0.8378843498938282
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,_SORAFENIB,"CARCINOMA, HEPATOCELLULAR",NCT02794337,Phase 2|Phase 3,0.05072816697836262,0.9492718330216376
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,_CELECOXIB,BLADDER CANCER,NCT02885974,Phase 1,0.3682484838936623,0.6317515161063376
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,_CELECOXIB,ANALGESIA,NCT03974932,Phase 3,0.3812578991532591,0.6187421008467406
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,_CELECOXIB,WILSON DISEASE,NCT04526197,Phase 1,0.21784532163018866,0.7821546783698115
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,_IMATINIB,STOMACH NEOPLASMS,NCT03170180,Phase 2,0.12935679237964112,0.8706432076203587
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,PANCREATIC CANCER,NCT03563248,Phase 2,0.3893963620055818,0.6106036379944181
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,"STRESS DISORDERS, POST-TRAUMATIC",NCT02560805,Phase 2,0.3414508803863932,0.6585491196136067
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,OSTEOSARCOMA,NCT03900793,Phase 1,0.585872853429558,0.414127146570442
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,"OBESITY, MORBID",NCT03519893,,0.3069819900197836,0.6930180099802165
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,_DASATINIB,ACUTE MYELOID LEUKEMIA,NCT02013648,Phase 3,0.18484623608334055,0.8151537639166594
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,_DASATINIB,"MYELOID LEUKEMIA, CHRONIC",NCT02890784,Phase 3,0.18484623608334055,0.8151537639166594
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,_CABOZANTINIB,NON SMALL CELL LUNG CANCER,NCT04131543,Phase 2,0.2617995370318256,0.7382004629681742
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,_CABOZANTINIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04471428,Phase 3,0.33927656826503194,0.6607234317349682
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,_CABOZANTINIB,METASTATIC RENAL CELL CARCINOMA,NCT03149822,Phase 1|Phase 2,0.5718238620147342,0.42817613798526577
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,_CABOZANTINIB,"CARCINOMA, RENAL CELL",NCT04338269,Phase 3,0.4113729128107764,0.5886270871892236
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,_CABOZANTINIB,BLADDER CANCER,NCT04289779,Phase 2,0.6003117309462958,0.39968826905370425
CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,_VEMURAFENIB,NON SMALL CELL LUNG CANCER,NCT03178552,Phase 2|Phase 3,0.6412336975652708,0.35876630243472923
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,_REGORAFENIB,GASTRIC CANCER,NCT03627728,Phase 2,0.14663759819650538,0.8533624018034947
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,_REGORAFENIB,RECTAL CANCER,NCT02910843,Phase 1,0.19042160904248076,0.8095783909575192
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,_REGORAFENIB,THYROID CANCER,NCT02657551,Phase 2,0.4976787008589066,0.5023212991410935
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,_REGORAFENIB,"CARCINOMA, HEPATOCELLULAR",NCT03347292,Phase 1,0.23328925006411105,0.7667107499358891
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,NON SMALL CELL LUNG CANCER,NCT03087448,Phase 1|Phase 2,0.6030499687981119,0.3969500312018882
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.3864495073995531,0.6135504926004468
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,MULTIPLE MYELOMA,NCT03091257,Phase 1,0.6226479971190515,0.3773520028809486
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,METASTATIC COLORECTAL CANCER,NCT03668431,Phase 2,0.6030499687981119,0.3969500312018882
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04452877,Phase 2,0.2575131271594059,0.7424868728405943
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,METASTATIC MELANOMA,NCT02392871,Phase 1|Phase 2,0.3772729232721714,0.6227270767278286
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,MENINGIOMA,NCT03631953,Phase 1,0.3772729232721714,0.6227270767278286
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.3306517428852056,0.6693482571147943
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,MULTIPLE MYELOMA,NCT03091257,Phase 1,0.6431117183324215,0.35688828166757863
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,METASTATIC COLORECTAL CANCER,NCT03668431,Phase 2,0.686558316459986,0.31344168354001417
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04452877,Phase 2,0.3209550445566687,0.679044955443331
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,METASTATIC MELANOMA,NCT02392871,Phase 1|Phase 2,0.34946353261428903,0.6505364673857108
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,_LENVATINIB,NON SMALL CELL LUNG CANCER,NCT03829332,Phase 3,0.3681611842875276,0.6318388157124724
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,_LENVATINIB,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT04199104,Phase 3,0.4378520841111274,0.5621479158888726
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,_LENVATINIB,BREAST CANCER,NCT03168074,Phase 2,0.2607271296828846,0.7392728703171155
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,_LENVATINIB,OSTEOSARCOMA,NCT04154189,Phase 2,0.4345821446247801,0.5654178553752199
COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O,_LENVATINIB,ADVANCED NON-SMALL CELL LUNG CANCER,NCT03516981,Phase 2,0.4378520841111274,0.5621479158888726
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,BREAST NEOPLASM,NCT03280563,Phase 1|Phase 2,0.4324066901960975,0.5675933098039024
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,BRAIN TUMOR,NCT03220646,Phase 2,0.6459979151598054,0.35400208484019474
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT03655444,Phase 1|Phase 2,0.6843835411752677,0.31561645882473216
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,PROSTATE CANCER,NCT03706365,Phase 2,0.40977487902452797,0.5902251209754721
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,BREAST CANCER,NCT04565054,Phase 3,0.33601953807071994,0.6639804619292801
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,GLIOBLASTOMA,NCT02977780,Phase 2,0.4963187156503575,0.5036812843496424
CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,_ABEMACICLIB,BLADDER CANCER,NCT03837821,Early Phase 1,0.6993192727834766,0.30068072721652345
C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,_LORLATINIB,NON SMALL CELL LUNG CANCER,NCT02927340,Phase 2,0.477979925304417,0.5220200746955829
C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,_LORLATINIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT03052608,Phase 3,0.4117407494483695,0.5882592505516304
C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,_LORLATINIB,ADVANCED CANCERS,NCT03726333,Phase 1,0.5555637258385437,0.44443627416145626
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,NON SMALL CELL LUNG CANCER,NCT03874000,Phase 2,0.5630295256559787,0.4369704743440213
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,BREAST CANCER,NCT04170465,Phase 2,0.27480544466747703,0.7251945553325231
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,COLON CANCER,NCT03359681,Phase 2,0.2821114457190158,0.7178885542809844
CN(C)C(=N)N=C(N)N.Cl,_METFORMIN_HYDROCHLORIDE,HEART FAILURE,NCT03331861,Phase 2,0.3837510742847882,0.6162489257152117
CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,_CARFILZOMIB,NEWLY DIAGNOSED MULTIPLE MYELOMA,NCT03742297,Phase 3,0.20401726326539207,0.7959827367346083
CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,_CARFILZOMIB,MANTLE CELL LYMPHOMA,NCT03891355,Phase 2,0.2481708022122304,0.7518291977877696
CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,_CARFILZOMIB,MULTIPLE MYELOMA,NCT03989414,Phase 1|Phase 2,0.2538800750300105,0.7461199249699898
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,_CLARITHROMYCIN,PARKINSON'S DISEASE,NCT03440112,Phase 1|Phase 2,0.4842914217420773,0.5157085782579227
CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,_IXAZOMIB,MANTLE CELL LYMPHOMA,NCT03616782,Phase 2,0.35866052644210794,0.6413394735578919
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,_THALIDOMIDE,DIFFUSE LARGE B-CELL LYMPHOMA,NCT02733380,Phase 2,0.07480721980957282,0.9251927801904272
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,_VINDESINE,DIFFUSE LARGE B CELL LYMPHOMA,NCT02767674,Phase 3,0.12816106684820122,0.8718389331517987
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,DIFFUSE LARGE B CELL LYMPHOMA,NCT03129828,Phase 1|Phase 2,0.16002524648928754,0.8399747535107127
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,PROSTATE CANCER,NCT02643667,Phase 1|Phase 2,0.5129978970841012,0.4870021029158989
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,LYMPHOMA,NCT02436707,Phase 2,0.3567990066137467,0.6432009933862531
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,GLIOBLASTOMA,NCT03535350,Phase 1,0.43512468853118336,0.5648753114688165
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,NON-HODGKIN'S LYMPHOMA,NCT03198026,Phase 2,0.5306276854455589,0.4693723145544409
C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1,_DUVELISIB,HEAD AND NECK SQUAMOUS CELL CARCINOMA,NCT04193293,Phase 1|Phase 2,0.9676448483941592,0.032355151605840585
C[C@H](Nc1ncnc2[nH]cnc12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1,_DUVELISIB,PERIPHERAL T CELL LYMPHOMA,NCT03372057,Phase 2,0.9428297095948316,0.05717029040516838
Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,_DECITABINE,BREAST NEOPLASM,NCT03295552,Phase 2,0.12165639403036335,0.8783436059696367
Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,_DECITABINE,LEUKEMIA,NCT01515527,Phase 2,0.33340694518500025,0.6665930548149999
Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,_DECITABINE,METASTATIC RENAL CELL CARCINOMA,NCT04049344,Phase 2,0.11213956770219967,0.8878604322978003
Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,_DECITABINE,HODGKIN LYMPHOMA,NCT03250962,Phase 2,0.017026993641700218,0.9829730063582997
Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,_DECITABINE,NON HODGKIN LYMPHOMA,NCT04337606,Phase 1|Phase 2,0.08263299912575528,0.9173670008742448
Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,_BENDAMUSTINE,DIFFUSE LARGE B CELL LYMPHOMA,NCT02753062,Phase 2,0.2468563114028304,0.7531436885971697
Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,_BENDAMUSTINE,MULTIPLE MYELOMA,NCT04083898,Phase 1|Phase 2,0.3265659495289905,0.6734340504710095
Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,_BENDAMUSTINE,DIFFUSE LARGE B-CELL LYMPHOMA,NCT02763319,Phase 2|Phase 3,0.14955813902535856,0.8504418609746414
Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21,_BENDAMUSTINE,PERIPHERAL T CELL LYMPHOMA,NCT04083495,Phase 2,0.41032433393235423,0.5896756660676457
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.10398192860140572,0.8960180713985945
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,"LYMPHOMA, T-CELL, CUTANEOUS",NCT03116659,Early Phase 1,0.6635603374388047,0.3364396625611953
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,INFERTILITY,NCT03824340,Not Applicable,0.10879467219745037,0.8912053278025498
C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O,_CARBIDOPA,AGE-RELATED MACULAR DEGENERATION,NCT03023059,Phase 2,0.2536189479148448,0.7463810520851549
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O,_EXENATIDE,PARKINSON'S DISEASE,NCT04305002,Phase 2,0.3071864614618998,0.6928135385381
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O,_EXENATIDE,SMOKING CESSATION,NCT02975297,Phase 1|Phase 2,0.3727389245494488,0.6272610754505511
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,_DICLOFENAC,BREAST CANCER,NCT04511832,Not Applicable,0.13811943643627125,0.8618805635637287
CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,_BUPRENORPHINE,"OBESITY, MORBID",NCT03460314,,0.2679945122814148,0.7320054877185853
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,IRREVERSIBLE PULPITIS,NCT04157036,Phase 3,0.1600141480600501,0.8399858519399498
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,ANALGESIA,NCT03955211,Phase 2,0.3143989755953214,0.6856010244046786
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,"OBESITY, MORBID",NCT03476577,,0.14963550826707178,0.8503644917329283
CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,_POSACONAZOLE,INVASIVE ASPERGILLOSIS,NCT04218851,Phase 2,0.18593420882823147,0.8140657911717688
CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O,_CASPOFUNGIN,FUNGAL INFECTION,NCT03857399,Phase 2,0.17300997101464613,0.8269900289853542
CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1,_TAZEMETOSTAT,METASTATIC PROSTATE CANCER,NCT04179864,Phase 1,0.772613320685807,0.2273866793141931
O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,_CIPROFLOXACIN,PNEUMONIA,NCT03177720,Phase 1,0.02169884166907004,0.97830115833093
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,_AMOXICILLIN,INFECTION,NCT03844776,Not Applicable,0.20356102224326744,0.7964389777567323
COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,_DEXTROMETHORPHAN,CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY,NCT02271893,Phase 2,0.16652454092061705,0.8334754590793831
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,_WARFARIN,PANCREATIC CANCER,NCT03536208,Early Phase 1,0.4357048710324877,0.5642951289675122
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,GLAUCOMA,NCT04052269,Phase 3,0.10969215695176047,0.8903078430482394
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,ERECTILE DYSFUNCTION|PROSTATE CANCER,NCT03406169,Phase 3,0.3796463357814421,0.6203536642185576
COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,_APIXABAN,"OBESITY, MORBID",NCT03448783,,0.31976884838233505,0.680231151617665
CCCC(CCC)C(=O)O,_VALPROIC_ACID,ACUTE MYELOID LEUKEMIA,NCT01369368,Phase 1|Phase 2,0.19318212260085932,0.806817877399141
CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,_PYRIMETHAMINE,MYELODYSPLASTIC SYNDROME,NCT03057990,Phase 1,0.5421601169749644,0.4578398830250357
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_CHLOROQUINE,ATRIAL FIBRILLATION,NCT02932007,Phase 2,0.4183201369190525,0.5816798630809474
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,PARKINSON'S DISEASE,NCT04342273,Phase 1,0.27479947236333124,0.7252005276366686
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,DIABETES,NCT01984827,Phase 1,0.3019122771817208,0.6980877228182792
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCC/N=C/N)C[C@H]12,_IMIPENEM,PNEUMONIA,NCT03177720,Phase 1,0.11915639643461992,0.8808436035653803
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,_ROFLUMILAST,ASTHMA,NCT04108377,Phase 1,0.2375359833362053,0.7624640166637948
O=C(O)Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1,_TETRAC,POST-DURAL PUNCTURE HEADACHE,NCT02813655,Phase 2,0.28903515196220825,0.7109648480377918
Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1,_CEFAZOLIN,BREAST NEOPLASM,NCT03742908,Not Applicable,0.110569718795642,0.8894302812043579
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,ULCERATIVE COLITIS,NCT02606032,Phase 2,0.12951057926336046,0.8704894207366395
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,INFECTION,NCT03844776,Not Applicable,0.1904636341597296,0.8095363658402703
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,_RIVAROXABAN,LIVER CIRRHOSIS,NCT03005444,Not Applicable,0.2806217900127954,0.7193782099872046
COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,_VENLAFAXINE,"OBESITY, MORBID",NCT03532477,,0.3159422971467588,0.6840577028532411
CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,_FLUOXETINE,"OBESITY, MORBID",NCT03476525,,0.16675404820776926,0.8332459517922305
CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,_DULOXETINE,OSTEO ARTHRITIS OF THE KNEES,NCT04224584,Phase 2,0.06772468112832958,0.9322753188716704
CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,_ESCITALOPRAM,"OBESITY, MORBID",NCT03460379,,0.30324019929788165,0.6967598007021185
NCC1(CC(=O)O)CCCCC1,_GABAPENTIN,"OBESITY, MORBID",NCT03476538,,0.16192267217307188,0.8380773278269282
Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,_LAMIVUDINE,COLORECTAL CANCER METASTATIC,NCT03144804,Phase 2,0.6409261575404392,0.3590738424595609
Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,_LAMIVUDINE,CHRONIC LYMPHOCYTIC LEUKEMIA,NCT03528941,,0.4476917767795077,0.5523082232204922
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_MINOCYCLINE,"STROKE, ISCHEMIC",NCT03320018,Phase 2|Phase 3,0.5069614184520159,0.4930385815479841
CC(C)C[C@H](CN)CC(=O)O,_PREGABALIN,NAUSEA,NCT04181346,Phase 2,0.01601920339119082,0.9839807966088092
COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,_CAPSAICIN,PARKINSON'S DISEASE,NCT03321019,,0.4704154994933684,0.5295845005066316
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,_OLANZAPINE,GASTRIC CANCER,NCT03575637,Phase 2,0.08877500920711537,0.9112249907928844
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,_RISPERIDONE,HUNTINGTON'S DISEASE,NCT04071639,Phase 1,0.18764487464167626,0.8123551253583241
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,_ARIPIPRAZOLE,TOURETTE SYNDROME,NCT03487783,Phase 3,0.16659935571605214,0.8334006442839478
Cc1nc2n(c(=O)c1CCN1CCC(C3NOc4cc(F)ccc43)CC1)CCCC2,_RISPERIDON,HUNTINGTON'S DISEASE,NCT04071639,Phase 1,0.3309138809084231,0.6690861190915769
CC(C)Cn1cnc2c(N)nc3ccccc3c21,_IMIQUIMOD,METASTATIC BREAST CANCER,NCT03982004,Phase 1,0.17933643801506313,0.8206635619849365
CC(C)Cn1cnc2c(N)nc3ccccc3c21,_IMIQUIMOD,"LYMPHOMA, T-CELL, CUTANEOUS",NCT03116659,Early Phase 1,0.2473160210108564,0.7526839789891436
c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1,_PLERIXAFOR,MULTIPLE MYELOMA,NCT03406091,,0.4944814711937986,0.5055185288062013
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,_CARVEDILOL,PROSTATE CANCER,NCT02944201,Phase 2,0.5551253006095287,0.44487469939047136
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,_CARVEDILOL,BREAST CANCER,NCT03879629,Phase 2,0.5595999798791699,0.4404000201208301
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OP(=O)(O)O,_ETOPOSIDE_PHOSPHATE,LYMPHOMA,NCT02106988,Phase 2,0.6339642664541544,0.3660357335458457
N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,_LIOTHYRONINE,HYPOTHYROIDISM,NCT03053115,Phase 2|Phase 3,0.2455634204616396,0.7544365795383602
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,PANCREATIC CANCER,NCT03434678,Phase 3,0.01950566009236741,0.9804943399076326
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,HEART FAILURE,NCT02421341,Not Applicable,0.01950566009236741,0.9804943399076326
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,ANALGESIA,NCT04442906,Not Applicable,0.012433116723033091,0.9875668832769671
Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,_ONDANSETRON,RECTAL CANCER,NCT03182179,Not Applicable,0.04014281975162394,0.959857180248376
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,COLORECTAL CANCER,NCT03273231,Not Applicable,0.01462015751836304,0.9853798424816368
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,POST TRAUMATIC STRESS DISORDER,NCT02727998,Phase 2,0.0561385741929186,0.9438614258070814
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,FATIGUE,NCT04141696,Phase 1|Phase 2,0.2000107074150938,0.7999892925849059
CNC1(c2ccccc2Cl)CCCCC1=O,_KETAMINE,SUBARACHNOID HEMORRHAGE,NCT02636218,Phase 2|Phase 3,0.09075495502484623,0.9092450449751536
FCOC(C(F)(F)F)C(F)(F)F,_SEVOFLURANE,ATRIAL FIBRILLATION,NCT02697448,Not Applicable,0.046526492532793146,0.9534735074672068
FCOC(C(F)(F)F)C(F)(F)F,_SEVOFLURANE,HEADACHE,NCT03789370,Not Applicable,0.0007734806629834255,0.9992265193370166
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,PANCREATIC CANCER,NCT03434678,Phase 3,0.0013491189427312774,0.9986508810572688
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,ANALGESIA,NCT03922048,Phase 2,0.11001114723883892,0.8899888527611612
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,UTERINE FIBROIDS,NCT04068766,Not Applicable,0.009966043280164429,0.9900339567198356
CCN(CC)CC(=O)Nc1c(C)cccc1C.Cl,_LIDOCAINE_HYDROCHLORIDE,PANCREATIC CANCER,NCT04048278,Early Phase 1,0.2624209443704961,0.7375790556295039
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,PANCREATIC CANCER,NCT03434678,Phase 3,0.011165841699071508,0.9888341583009284
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,ATRIAL FIBRILLATION,NCT02697448,Not Applicable,0.011165841699071508,0.9888341583009284
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,HEADACHE,NCT03789370,Not Applicable,0.0022079103630205737,0.9977920896369794
CNC[C@H](O)c1ccc(O)c(O)c1,_EPINEPHRINE,SCAR,NCT02234193,Early Phase 1,0.20912033847398084,0.7908796615260194
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,_TRIAMCINOLONE,CHALAZION,NCT02025023,Phase 3,0.32882082639401633,0.6711791736059836
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,_TRIAMCINOLONE,AGE-RELATED MACULAR DEGENERATION,NCT04292756,Not Applicable,0.029422684645877294,0.9705773153541226
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,_TRIAMCINOLONE,PSORIASIS,NCT04117919,Phase 2,0.029422684645877294,0.9705773153541226
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_TRIAMCINOLONE_ACETONIDE,CHALAZION,NCT02025023,Phase 3,0.5604345556549246,0.4395654443450756
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_TRIAMCINOLONE_ACETONIDE,AGE-RELATED MACULAR DEGENERATION,NCT04292756,Not Applicable,0.2928343109110206,0.7071656890889796
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,_OXYCODONE,PARKINSON'S DISEASE,NCT02601586,Phase 2|Phase 3,0.11855120604382438,0.8814487939561755
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314,_OXYCODONE,COLORECTAL CANCER,NCT03253133,Phase 1,0.17825394443984266,0.8217460555601575
CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,_DIAZEPAM,CONTRACEPTION,NCT02799641,Not Applicable,0.4861095951311815,0.5138904048688184
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,BLADDER CANCER,NCT01935466,,0.17066534683912893,0.8293346531608711
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,MULTIPLE SCLEROSIS,NCT03109288,Phase 1|Phase 2,0.4112073477854396,0.5887926522145606
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,ACUTE MYELOID LEUKEMIA,NCT02942758,Phase 2,0.13348846532101502,0.8665115346789848
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,CHRONIC MYELOID LEUKEMIA,NCT02889003,Phase 2,0.19879149972591156,0.8012085002740883
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,OBESITY,NCT03866408,Early Phase 1,0.1701585588556183,0.8298414411443816
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,GASTROPARESIS,NCT04300127,Early Phase 1,0.5156166946776055,0.4843833053223945
CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,_TIMOLOL,HEMANGIOMA,NCT01873131,Not Applicable,0.11458120082353818,0.8854187991764618
CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\C(=O)O,_TIMOLOL_MALEATE,HEMANGIOMA,NCT01873131,Not Applicable,0.26833274632753673,0.7316672536724633
Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(OC(N)=O)C1O)c1c[nH]cn1,_BLEOMYCIN,GASTRIC CANCER,NCT04139070,Phase 1,0.4680865277811456,0.5319134722188544
CN(C)/N=N/c1[nH]cnc1C(N)=O,_DACARBAZINE,HODGKIN LYMPHOMA,NCT03033914,Phase 1|Phase 2,0.323835319347377,0.6761646806526228
O=S(=O)(O)CCS,_MESNA,LYMPHOMA,NCT02436707,Phase 2,0.3093579042985121,0.6906420957014879
O=S(=O)(O)CCS,_MESNA,RETINOBLASTOMA,NCT01783535,Phase 2,0.38523746976278667,0.6147625302372134
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,OBESITY,NCT03043053,Phase 2,0.3454623062607846,0.6545376937392152
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,POSTOPERATIVE PAIN,NCT03011307,Phase 2,0.3892155849353396,0.6107844150646604
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,NEUROPATHIC PAIN,NCT02100956,Phase 2,0.4008459699058702,0.5991540300941299
C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,_ROCURONIUM,PROSTATE CANCER,NCT03808077,Phase 2,0.1350404053870709,0.8649595946129289
C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,_ROCURONIUM,PANCREATIC CANCER,NCT03434678,Phase 3,0.11964771317805413,0.8803522868219459
Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,_NALBUPHINE,POSTOPERATIVE COMPLICATIONS,NCT03470077,Phase 2,0.12418700950214365,0.8758129904978564
CCCN[C@H]1CCc2nc(N)sc2C1,_PRAMIPEXOLE,CHRONIC PAIN,NCT03842709,Early Phase 1,0.13563392972224755,0.8643660702777524
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,PAIN,NCT04034004,Early Phase 1,0.16081234850376944,0.8391876514962304
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,EPILEPSY,NCT02332447,Phase 3,0.11195048566397844,0.8880495143360218
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,BURN,NCT03513406,Phase 3,0.1208622425904198,0.8791377574095803
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,GASTRIC CANCER,NCT04205097,Not Applicable,0.1158073393374475,0.8841926606625526
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,POSTOPERATIVE PAIN,NCT04544228,Not Applicable,0.09229122116287176,0.9077087788371284
C=C1[C@@H](n2cnc3c(=O)nc(N)[nH]c32)C[C@H](O)[C@H]1CO,_ENTECAVIR,COLORECTAL NEOPLASMS,NCT02777814,Phase 2,0.01322308406368598,0.986776915936314
COc1cc(CC(C)N)c(OC)cc1C,_DOM,STROKE,NCT03828851,Not Applicable,0.1492840632222863,0.8507159367777138
COc1cc(CC(C)N)c(OC)cc1C,_DOM,GASTROPARESIS,NCT03810287,Early Phase 1,0.524960028010008,0.475039971989992
COc1cc(CC(C)N)c(OC)cc1C,_DOM,HEMOPHILIA A,NCT03818763,Phase 1,0.5261119102388094,0.4738880897611906
CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,_SOFOSBUVIR,HEPATITIS B INFECTION,NCT03312023,Phase 2,0.6182937991919583,0.3817062008080418
COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C,_LEDIPASVIR,HEPATITIS B INFECTION,NCT03312023,Phase 2,0.5738046312370361,0.4261953687629639
NC[C@H]1CC[C@H](C(=O)O)CC1,_TRANEXAMIC_ACID,BLADDER CANCER,NCT01869413,Phase 2|Phase 3,0.031752645388066165,0.9682473546119336
CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC,_MISOPROSTOL,CLOSTRIDIUM DIFFICILE,NCT03617172,Phase 2,0.4712868052737055,0.5287131947262944
CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,_MITOMYCIN,COLORECTAL CANCER,NCT02614534,Phase 3,0.04766993466347589,0.952330065336524
O.O.O.O.O.O=S([O-])([O-])=S.[Na+].[Na+],_SODIUM_THIOSULFATE,CENTRAL NERVOUS SYSTEM LYMPHOMA,NCT00293475,Phase 1|Phase 2,0.937974654267318,0.062025345732681814
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,_VANDETANIB,NEOPLASMS,NCT02530411,Phase 2,0.2566616202829497,0.7433383797170504
NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,_HYDROCHLOROTHIAZIDE,"OBESITY, MORBID",NCT03476551,,0.2484111011667313,0.7515888988332686
[Cl-].[K+],_POTASSIUM_CHLORIDE,HEART FAILURE,NCT02840799,Phase 2,0.2685443100976943,0.7314556899023055
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,_BROMOCRIPTINE,OBESITY,NCT03525002,Phase 2,0.21078224239320006,0.7892177576067999
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,_GEFITINIB,LUNG CANCER,NCT03292133,Phase 2,0.39022575208515264,0.6097742479148474
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,_GEFITINIB,STOMACH NEOPLASMS,NCT03170180,Phase 2,0.16101195442106636,0.8389880455789335
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,_GEFITINIB,NSCLC,NCT02856893,Phase 2,0.1056092389331372,0.8943907610668629
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,_OSIMERTINIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT03784599,Phase 2,0.2413318866481864,0.7586681133518137
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,_OSIMERTINIB,LUNG CANCER,NCT03567642,Phase 1,0.5647472489091354,0.4352527510908646
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,_OSIMERTINIB,NSCLC,NCT02856893,Phase 2,0.2296858743650845,0.7703141256349154
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,_OSIMERTINIB,METASTATIC NON SMALL CELL LUNG CANCER,NCT03497767,Phase 2,0.18409425680846614,0.8159057431915337
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,_CRIZOTINIB,NON SMALL CELL LUNG CANCER,NCT03375242,,0.5174584924925456,0.4825415075074542
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,_CRIZOTINIB,NEOPLASMS,NCT03194893,Phase 3,0.4540842492566358,0.5459157507433642
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,NON SMALL CELL LUNG CANCER,NCT03267654,Phase 2,0.25960684730270595,0.7403931526972941
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,PANCREATIC CANCER,NCT04415385,Phase 2,0.008274201895700377,0.9917257981042996
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,COLORECTAL CANCER,NCT04446091,Phase 1|Phase 2,0.08294167867007733,0.9170583213299226
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,GLIOBLASTOMA,NCT03567135,,0.1300110518366361,0.8699889481633639
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.008274201895700377,0.9917257981042996
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,HEAD AND NECK NEOPLASMS,NCT02989259,Phase 2,0.008274201895700377,0.9917257981042996
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,GLIOMA,NCT03741244,Phase 2,0.09164119581894067,0.9083588041810592
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,NSCLC,NCT03801200,Phase 2,0.09164119581894067,0.9083588041810592
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,COLORECTAL NEOPLASMS,NCT03743428,Not Applicable,0.09164119581894067,0.9083588041810592
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,HEAD AND NECK CANCER,NCT03654612,Phase 1|Phase 2,0.008274201895700377,0.9917257981042996
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,NON SMALL CELL LUNG CANCER,NCT03267654,Phase 2,0.25960684730270595,0.7403931526972941
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,PANCREATIC CANCER,NCT04415385,Phase 2,0.008274201895700377,0.9917257981042996
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,COLORECTAL CANCER,NCT04446091,Phase 1|Phase 2,0.08294167867007733,0.9170583213299226
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,GLIOBLASTOMA,NCT03567135,,0.1300110518366361,0.8699889481633639
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.008274201895700377,0.9917257981042996
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,HEAD AND NECK NEOPLASMS,NCT02989259,Phase 2,0.008274201895700377,0.9917257981042996
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,GLIOMA,NCT03741244,Phase 2,0.09164119581894067,0.9083588041810592
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,NSCLC,NCT03801200,Phase 2,0.09164119581894067,0.9083588041810592
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,COLORECTAL NEOPLASMS,NCT03743428,Not Applicable,0.09164119581894067,0.9083588041810592
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,HEAD AND NECK CANCER,NCT03654612,Phase 1|Phase 2,0.008274201895700377,0.9917257981042996
C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21,_SAVOLITINIB,NON SMALL CELL LUNG CANCER,NCT03944772,Phase 2,0.5652584171253395,0.4347415828746605
C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21,_SAVOLITINIB,PROSTATE CANCER,NCT03385655,Phase 2,0.4992448487055762,0.5007551512944238
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,_ICOTINIB,LUNG CANCER,NCT01996098,Phase 3,0.05434483391088296,0.945655166089117
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,_ICOTINIB,METASTATIC BREAST CANCER,NCT02362230,Phase 2,0.2350688084230433,0.7649311915769565
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,_ICOTINIB,NON-SQUAMOUS NSCLC,NCT03992885,Phase 3,0.2286394035222265,0.7713605964777733
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,_TOPOTECAN,OVARIAN CANCER,NCT03763123,Phase 1,0.3537345413408044,0.6462654586591955
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,_TOPOTECAN,SMALL CELL LUNG CANCER,NCT03088813,Phase 2|Phase 3,0.3000259797138993,0.6999740202861007
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,_TOPOTECAN,RETINOBLASTOMA,NCT01783535,Phase 2,0.459588502079589,0.5404114979204111
CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,_ATENOLOL,"STRESS DISORDERS, POST-TRAUMATIC",NCT02560805,Phase 2,0.3137878955817637,0.6862121044182363
CCN(CC)C(=S)SSC(=S)N(CC)CC,_DISULFIRAM,GLIOBLASTOMA,NCT03151772,Early Phase 1,0.17413510150607206,0.8258648984939281
CCN(CC)C(=S)SSC(=S)N(CC)CC,_DISULFIRAM,METASTATIC BREAST CANCER,NCT04265274,Phase 2,0.2495611246557067,0.7504388753442934
CCN(CC)C(=S)SSC(=S)N(CC)CC,_DISULFIRAM,GLIOBLASTOMA MULTIFORME,NCT02715609,Phase 1|Phase 2,0.2786852270712084,0.7213147729287919
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_ALBUTEROL,MYASTHENIA GRAVIS,NCT03914638,Phase 2|Phase 3,0.10628643984893882,0.8937135601510614
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_ALBUTEROL,INSULIN RESISTANCE,NCT04558190,Not Applicable,0.11890014109105447,0.8810998589089458
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_SALBUTAMOL,MYASTHENIA GRAVIS,NCT03914638,Phase 2|Phase 3,0.10628643984893882,0.8937135601510614
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_SALBUTAMOL,INSULIN RESISTANCE,NCT04558190,Not Applicable,0.11890014109105447,0.8810998589089458
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE,PARKINSON'S DISEASE,NCT04164758,Phase 2,0.2418058355861032,0.7581941644138966
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE,"OBESITY, MORBID",NCT03449472,,0.2459765657477434,0.7540234342522567
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE,POST TRAUMATIC STRESS DISORDER,NCT04280965,Early Phase 1,0.1929180908488532,0.8070819091511469
C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,_APREPITANT,NON SMALL CELL LUNG CANCER,NCT02646020,Phase 2,0.06246915099518568,0.9375308490048144
C[C@@H](O[C@H]1OCCN(Cc2nc(=O)n(P(=O)(O)O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,_FOSAPREPITANT,MULTIPLE MYELOMA,NCT02780609,Phase 1|Phase 2,0.606114484658689,0.3938855153413111
COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,_CLOPIDOGREL,HEAD AND NECK CANCER,NCT03245489,Phase 1,0.18642563615550425,0.8135743638444959
CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,_MEGESTROL_ACETATE,BREAST CANCER,NCT03306472,Phase 2,0.12164815407771265,0.8783518459222874
NCCCC[C@H](N)C(=O)O,_LYSINE,HEART FAILURE,NCT03446651,Early Phase 1,0.6710446561779283,0.32895534382207176
C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,_ARTESUNATE,COLORECTAL CANCER,NCT03093129,Phase 2,0.3419110627941745,0.6580889372058255
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,_PYROTINIB,COLORECTAL CANCER,NCT03843749,Not Applicable,0.4963348656633292,0.5036651343366707
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,_PYROTINIB,METASTATIC BREAST CANCER,NCT04034589,Phase 2,0.5092434812459498,0.4907565187540502
Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1,_MOCETINOSTAT,"CARCINOMA, NON-SMALL-CELL LUNG",NCT02954991,Phase 2,0.8093348790612808,0.19066512093871932
Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1,_MOCETINOSTAT,LUNG CANCER,NCT03220477,Phase 1,0.9147617599940342,0.08523824000596576
Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1,_MOCETINOSTAT,RHABDOMYOSARCOMA,NCT04299113,Phase 1,0.7933555997078265,0.2066444002921736
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@@H]2CCCCO2)[C@H](C)O1,_PIRARUBICIN,SOFT TISSUE SARCOMA,NCT04126811,Phase 2,0.044565527182708634,0.9554344728172912
Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[Na+].[Na+],_PEMETREXED_DISODIUM,NON SMALL CELL LUNG CANCER,NCT04379635,Phase 3,0.5117448615213934,0.4882551384786066
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,_DOBUTAMINE,MYOCARDIAL INFARCTION,NCT03289728,Not Applicable,0.11929557071744487,0.8807044292825555
CN1CCN2c3ncccc3Cc3ccccc3C2C1,_MIRTAZAPINE,BREAST CANCER,NCT02336750,Phase 3,0.10574875561682943,0.8942512443831707
NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,_FUROSEMIDE,ACTINIC KERATOSIS,NCT03684772,Phase 2,0.4744089817803994,0.5255910182196005
NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,_FUROSEMIDE,NEPHROTIC SYNDROME,NCT03750136,Not Applicable,0.5754904146016199,0.4245095853983804
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,BREAST CANCER,NCT02395614,Not Applicable,0.382405609526971,0.617594390473029
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,INFECTION,NCT03844776,Not Applicable,0.0870142758457877,0.9129857241542124
C[C@@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C)C(C)(C)O,_PARICALCITOL,PANCREATIC CANCER,NCT04054362,Phase 2,0.20845873345289975,0.7915412665471006
Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,_ZOLPIDEM,PROSTATIC NEOPLASMS,NCT03436745,Phase 1,0.2988526424824882,0.7011473575175118
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F,_TRIFLURIDINE,METASTATIC COLORECTAL CANCER,NCT04166604,Phase 2,0.4782160032477709,0.5217839967522291
O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F,_TRIFLURIDINE,COLORECTAL CANCER,NCT03974594,Phase 1,0.21514540779763008,0.7848545922023703
OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,_MANNITOL,CENTRAL NERVOUS SYSTEM LYMPHOMA,NCT00293475,Phase 1|Phase 2,0.6956449810201132,0.304355018979887
OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,_MANNITOL,SUBARACHNOID HEMORRHAGE,NCT04135456,Not Applicable,0.20425967803968026,0.7957403219603196
O=c1[nH]c(=O)n(C2CCCO2)cc1F,_TEGAFUR,GASTRIC CANCER,NCT03006705,Phase 3,0.16042342303648027,0.8395765769635198
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2n1cnc2ccccc21,_GALETERONE,ADVANCED PANCREATIC CANCER,NCT04098081,Phase 2,0.39835890907583255,0.6016410909241674
Nc1nc(=O)c2c([nH]1)NC[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O,_FOLINIC_ACID,RECTAL CANCER,NCT02704520,Phase 2|Phase 3,0.7820156982818033,0.21798430171819674
Nc1nc(=O)c2c([nH]1)NC[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O,_FOLINIC_ACID,COLORECTAL CANCER METASTATIC,NCT03751176,Phase 2,0.9022309982475444,0.09776900175245563
Nc1nc(=O)c2c([nH]1)NC[C@@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O,_FOLINIC_ACID,ADVANCED COLORECTAL CANCER,NCT04252456,Not Applicable,0.9166918875989124,0.08330811240108763
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(CO)=N/NC(=O)CCCCCN1C(=O)C=CC1=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_ALDOXORUBICIN,PANCREATIC CANCER,NCT04390399,Phase 2,0.996140148520204,0.003859851479796107
C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)[C@@]1(C)C3=CC=C(C(=O)OC)[C@H]1C(=O)OC,_VERTEPORFIN,RECURRENT PROSTATE CANCER,NCT03067051,Phase 1,0.3754665706487913,0.6245334293512087
CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,_DRONABINOL,OSTEO ARTHRITIS OF THE KNEES,NCT04298528,Phase 3,0.12721585440812036,0.8727841455918799
CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,_DRONABINOL,CHRONIC PAIN,NCT03766269,Phase 2,0.2888198555514676,0.7111801444485323
CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F,_UMBRALISIB,CHRONIC LYMPHOCYTIC LEUKEMIA,NCT04016805,Phase 2,0.7612424547690906,0.23875754523090936
CC(=O)O,_ACETIC_ACID,ADENOMA COLON,NCT04464135,Not Applicable,0.3459896029423917,0.6540103970576082
CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,_ITRACONAZOLE,LUNG CANCER,NCT03664115,Phase 2,0.10344442736105666,0.8965555726389434
CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(=O)C[C@@H]21,_NABILONE,PARKINSON'S DISEASE,NCT03773796,Phase 3,0.2986545945163159,0.7013454054836841
COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O,_COENZYME_Q1,HUNTINGTON'S DISEASE,NCT04071639,Phase 1,0.4561781166039458,0.543821883396054
NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,_RIBAVIRIN,ACUTE MYELOID LEUKEMIA,NCT03760666,Phase 1|Phase 2,0.2587720424594924,0.7412279575405077
NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,_RIBAVIRIN,"HEPATITIS B, CHRONIC",NCT03759782,Phase 3,0.054823725911710315,0.9451762740882896
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,PARKINSON'S DISEASE,NCT03575195,Phase 1|Phase 2,0.6485479345518358,0.3514520654481645
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,_RIFAXIMIN,TYPE 2 DIABETES,NCT03758144,Not Applicable,0.4426814131203496,0.5573185868796504
NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O,_PEVONEDISTAT,NON SMALL CELL LUNG CANCER,NCT03228186,Phase 2,0.7638573102951237,0.23614268970487626
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,_URSODIOL,LIVER DISEASES,NCT02943707,Phase 2,0.16218297415316169,0.8378170258468384
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,_URSODEOXYCHOLIC_ACID,LIVER DISEASES,NCT02943707,Phase 2,0.16218297415316169,0.8378170258468384
COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,_BOSUTINIB,DEMENTIA WITH LEWY BODIES,NCT03888222,Phase 2,0.4964547778095653,0.5035452221904346
COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,_BOSUTINIB,CHRONIC MYELOID LEUKEMIA,NCT03831776,Phase 2,0.3238112285798411,0.6761887714201587
COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,_BOSUTINIB,CHRONIC MYELOGENOUS LEUKEMIA,NCT02501330,,0.3765593023033298,0.6234406976966701
CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)NCCNC(=O)COc2cccc([C@@H](CCc3ccc(OC)c(OC)c3)OC(=O)[C@@H]3CCCCN3C(=O)[C@@H](CC)c3cc(OC)c(OC)c(OC)c3)c2)c1)c1cc(OC)c(OC)c(OC)c1,_RIMIDUCID,MULTIPLE MYELOMA,NCT03288493,Phase 1|Phase 2,0.9447126869487792,0.055287313051220914
COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F,_IDASANUTLIN,COLORECTAL CANCER,NCT03555149,Phase 1|Phase 2,0.9352464480854396,0.06475355191456053
CCOc1c([C@H](C)n2nc(C)c3c(N)ncnc32)cc(Cl)c(F)c1[C@@H]1CNC(=O)C1,_PARSACLISIB,LYMPHOMA,NCT03235544,Phase 2,0.7705693127358124,0.22943068726418755
Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1,_TUCIDINOSTAT,BREAST CANCER,NCT04465097,Phase 2,0.3163096839846485,0.6836903160153517
Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1,_TUCIDINOSTAT,DIFFUSE LARGE B-CELL LYMPHOMA,NCT04231448,Phase 3,0.3623111960729871,0.6376888039270129
CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O,_PLINABULIN,NON SMALL CELL LUNG CANCER,NCT02504489,Phase 3,0.6245282427900322,0.3754717572099678
CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O,_PLINABULIN,NON-SMALL CELL LUNG CANCER METASTATIC,NCT02812667,Phase 1,0.9241018990691529,0.07589810093084731
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,_NILOTINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.09378510603851484,0.9062148939614852
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,_NILOTINIB,DEMENTIA WITH LEWY BODIES,NCT04002674,Phase 2,0.4586401626433774,0.5413598373566226
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,_NILOTINIB,HUNTINGTON'S DISEASE,NCT03764215,Phase 1,0.2898943691384049,0.7101056308615951
COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,_ZAFIRLUKAST,OVARIAN CANCER,NCT04339140,Phase 2,0.6952775908025488,0.30472240919745097
FC(F)(F)C(F)(F)C(F)(F)F,_PERFLUTREN,KIDNEY CANCER,NCT04021238,Phase 2,0.5483825500211337,0.4516174499788663
FC(F)(F)C(F)(F)C(F)(F)F,_PERFLUTREN,HEPATOCELLULAR CARCINOMA|LIVER CANCER,NCT03199274,Early Phase 1,0.4286822882876569,0.571317711712343
FS(F)(F)(F)(F)F,_SULFUR_HEXAFLUORIDE,KIDNEY CANCER,NCT04021238,Phase 2,0.6021360722002451,0.3978639277997551
O=[As]O[As]=O,_ARSENIC_TRIOXIDE,AML,NCT03031249,Phase 1|Phase 2,0.14277592055372285,0.8572240794462772
O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,_SUGAMMADEX,BURN,NCT03513406,Phase 3,0.13052435574181648,0.8694756442581836
O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,_SUGAMMADEX,GASTRIC CANCER,NCT04205097,Not Applicable,0.08457033350158766,0.9154296664984124
CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,_ETODOLAC,COLORECTAL NEOPLASMS,NCT03919461,Phase 2,0.2518718396339059,0.7481281603660942
O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1,_SOLIFENACIN,OVERACTIVE BLADDER|PARKINSON DISEASE,NCT03149809,Phase 3,0.21966985351684948,0.7803301464831505
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,_ENALAPRIL,"OBESITY, MORBID",NCT03460366,,0.4760895611453793,0.5239104388546207
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF,_FLUTICASONE,PHARMACOKINETICS,NCT03739294,Phase 2,0.1832095345891528,0.8167904654108471
CC(O)CN1CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC1.[Gd+3],_GADOTERIDOL,GLIOBLASTOMA,NCT02359097,Not Applicable,0.7205677564604546,0.27943224353954543
CC(O)CN1CCN(CC(=O)[O-])CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC1.[Gd+3],_GADOTERIDOL,MULTIPLE SCLEROSIS,NCT03396822,,0.5462891165720639,0.453710883427936
[Fe+2].[Fe+3].[Fe+3].[O-2].[O-2].[O-2].[O-2],_FERUMOXYTOL,GLIOBLASTOMA,NCT02359097,Not Applicable,0.7725966723262584,0.2274033276737417
[Fe+2].[Fe+3].[Fe+3].[O-2].[O-2].[O-2].[O-2],_FERUMOXYTOL,BRAIN NEOPLASM,NCT03234309,Phase 2,0.7057273728475201,0.2942726271524799
CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)=O)cc1,_SULINDAC,COLORECTAL NEOPLASMS,NCT01349881,Phase 3,0.8728660015015538,0.12713399849844628
NCCCC(N)(C(=O)O)C(F)F,_EFLORNITHINE,COLORECTAL NEOPLASMS,NCT01349881,Phase 3,0.7865841230404983,0.21341587695950184
Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3,_BUTORPHANOL,AGITATION,NCT03398759,Not Applicable,0.07888084373268117,0.921119156267319
Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3,_BUTORPHANOL,COLONOSCOPY,NCT04477733,Not Applicable,0.07888084373268117,0.921119156267319
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cnccn5)n4)c3)cc(C(F)(F)F)c2)cn1,_RADOTINIB,"CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE",NCT03722420,Phase 3,0.5765287653125359,0.4234712346874641
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,PROSTATE CANCER,NCT03716739,Phase 2,0.2793020304333697,0.7206979695666305
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,LIVER CIRRHOSIS,NCT03995251,Not Applicable,0.03863320789996754,0.9613667921000328
CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,_TESTOSTERONE_ENANTHATE,PROSTATE CANCER,NCT02090114,Phase 2,0.5135390342384802,0.4864609657615198
CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,_KETOCONAZOLE,PROSTATE CANCER,NCT00859781,Phase 2,0.7864967726324723,0.21350322736752755
O=C(O)c1cccnc1,_NIACIN,POST TRAUMATIC STRESS DISORDER,NCT03752918,Phase 1,0.19093751331803815,0.8090624866819616
O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,_NICLOSAMIDE,FAMILIAL ADENOMATOUS POLYPOSIS,NCT04296851,Phase 2,0.3434182094403081,0.6565817905596919
N[C@]1(C(=O)O)C[C@@H](F)C1,_FLUCICLOVINE,PROSTATE CANCER,NCT04009083,Not Applicable,0.3095306991741999,0.6904693008258
N[C@]1(C(=O)O)C[C@@H](F)C1,_FLUCICLOVINE,PROSTATE ADENOCARCINOMA,NCT03762759,Phase 2,0.3862855318610304,0.6137144681389697
N[C@]1(C(=O)O)C[C@@H](F)C1,_FLUCICLOVINE,GLIOBLASTOMA,NCT03926507,Early Phase 1,0.3445872757958645,0.6554127242041352
Nc1[nH]c(=O)ncc1F,_FLUCYTOSINE,COLORECTAL NEOPLASMS,NCT04194034,Phase 1|Phase 2,0.8196868799075305,0.18031312009246972
CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,_LOPERAMIDE,COLORECTAL CANCER METASTATIC,NCT03705442,Phase 2,0.14204117913241604,0.857958820867584
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,NON SMALL CELL LUNG CANCER,NCT02570815,Phase 1,0.14228155928281258,0.8577184407171875
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,LUNG CANCER,NCT04182152,Not Applicable,0.2000879935231896,0.7999120064768106
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,HEPATOCELLULAR CARCINOMA,NCT04258566,Phase 1,0.5878040940293097,0.4121959059706902
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,RHEUMATOID ARTHRITIS,NCT02680067,Phase 1,0.6144659303239637,0.3855340696760364
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,ENDOMETRIOSIS,NCT03950206,Not Applicable,0.1474205886014821,0.8525794113985179
CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,_TAMSULOSIN,URINARY RETENTION,NCT03609580,Phase 1|Phase 2,0.5119054843258017,0.4880945156741984
C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-],_GLYCOPYRROLATE,BURN,NCT03513406,Phase 3,0.16121255133310505,0.8387874486668951
O=[N+]([O-])[O-],_NITRATE,HEART FAILURE,NCT02840799,Phase 2,0.4195513670779777,0.5804486329220224
O=[N+]([O-])[O-],_NITRATE,ERECTILE DYSFUNCTION,NCT04116060,Not Applicable,0.2443857714790354,0.7556142285209646
O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Cu+2],_COPPER_GLUCONATE,GLIOBLASTOMA MULTIFORME,NCT02715609,Phase 1|Phase 2,0.6269968706791452,0.3730031293208549
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,_MIFEPRISTONE,NON SMALL CELL LUNG CANCER,NCT02642939,Phase 2,0.4695990960181184,0.5304009039818814
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,_MIFEPRISTONE,BREAST CANCER,NCT02788981,Phase 2,0.2964355117564159,0.7035644882435841
CC(=O)C(=O)O,_PYRUVATE,PROSTATE CANCER,NCT02913131,Phase 1|Phase 2,0.7852944500491478,0.21470554995085225
CC(=O)C(=O)O,_PYRUVATE,BREAST CANCER,NCT03121989,Phase 1,0.6348279740169448,0.3651720259830553
CC(=O)C(=O)O,_PYRUVATE,PROSTATE ADENOCARCINOMA,NCT03933670,Phase 2,0.8842773874157995,0.11572261258419995
CC(=O)C(=O)O,_PYRUVATE,GLIOMA,NCT03739411,Phase 1,0.7390577666194136,0.2609422333805866
CC(=O)C(=O)O,_PYRUVATE,PANCREATIC DUCTAL ADENOCARCINOMA,NCT04565327,Phase 2,0.5603649881810747,0.4396350118189253
C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1,_PACRITINIB,BREAST CANCER,NCT04520269,Phase 1|Phase 2,0.7959862100053043,0.2040137899946956
CN1[C@H]2CCC[C@@H]1C[C@H](NC(=O)c1nn(C)c3ccccc13)C2,_GRANISETRON,SEPSIS,NCT03924518,Phase 2,0.06690870289506043,0.9330912971049397
Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,_OXYMETAZOLINE,FECAL INCONTINENCE,NCT03529487,Phase 1,0.35299136438930384,0.6470086356106961
CCOC(=O)c1ccc(N)cc1,_BENZOCAINE,OBESITY,NCT02537314,Phase 1,0.1846297024556215,0.8153702975443784
Nc1ccc2cc3ccc(N)cc3nc2c1,_PROFLAVINE,BARRETT'S ESOPHAGUS,NCT02018367,Phase 2,0.7083486811586801,0.2916513188413204
CN(C)CCC=C1c2ccccc2COc2ccccc21,_DOXEPIN,BREAST CANCER,NCT02447211,Phase 2,0.17055447900549153,0.8294455209945084
COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,_TERAZOSIN,PARKINSON'S DISEASE,NCT03905811,Phase 1|Phase 2,0.2508872921139164,0.7491127078860836
CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2,_FLUMAZENIL,PARKINSON'S DISEASE,NCT03462641,Phase 1|Phase 2,0.28697727976574017,0.7130227202342598
O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,_DOMPERIDONE,GASTROPARESIS,NCT03810287,Early Phase 1,0.5795041954000127,0.4204958045999874
CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,_PIMAVANSERIN,PARKINSON'S DISEASE,NCT04164758,Phase 2,0.2558926425857579,0.744107357414242
Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1,_TOMIVOSERTIB,BREAST CANCER,NCT04261218,Phase 1,0.805409859877212,0.19459014012278766
Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl,_AFURESERTIB,METASTATIC CASTRATION-RESISTANT PROSTATE CANCER,NCT04060394,Phase 1|Phase 2,0.8039570706290621,0.19604292937093784
CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12,_FRUQUINTINIB,METASTATIC COLORECTAL CANCER,NCT03977090,Phase 1,0.4479547285478799,0.55204527145212
CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12,_FRUQUINTINIB,COLORECTAL CANCER,NCT04431791,,0.3381435129848653,0.6618564870151346
CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21,_CHLORPROTHIXENE,"OBESITY, MORBID",NCT03449485,,0.4069988413676213,0.5930011586323787
CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1,_VISTUSERTIB,NON SMALL CELL LUNG CANCER,NCT03334617,Phase 2,0.7364917409339549,0.2635082590660449
CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,_CAPMATINIB,NON SMALL CELL LUNG CANCER,NCT04139317,Phase 2,0.7189214403168279,0.2810785596831724
CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,_CAPMATINIB,SOFT TISSUE SARCOMA,NCT03784014,Phase 3,0.5937510181785407,0.40624898182145947
CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,_CAPMATINIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04427072,Phase 3,0.7189214403168279,0.2810785596831724
CCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1,_SAPACITABINE,BREAST CANCER,NCT03641755,Phase 1|Phase 2,0.8941195303287897,0.10588046967121027
COC1=CC(=O)OC(/C=C/C2=CCCC=C2)C1,_KAVA,PHARMACOKINETICS,NCT03843502,Phase 1,0.6241231311337141,0.3758768688662862
O=C(Oc1ccccc1C(=O)O)c1ccccc1O,_SALSALATE,PCOS,NCT03229408,Phase 2,0.465203600496372,0.534796399503628
OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_SUCROSE,PAIN,NCT04313179,Not Applicable,0.4034793172028028,0.596520682797197
O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,_GENISTEIN,BLADDER CANCER,NCT01489813,Phase 2,0.8130861372199496,0.18691386278005048
Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,_RESVERATROL,DILATED CARDIOMYOPATHY,NCT01914081,Phase 3,0.44777055006318905,0.552229449936811
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,PAIN,NCT04132609,Not Applicable,0.5124026163609191,0.4875973836390809
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,ANXIETY,NCT04245501,Not Applicable,0.6173157141323525,0.3826842858676474
Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C,_TIPIFARNIB,NON SMALL CELL LUNG CANCER,NCT03496766,Phase 2,0.633895522781677,0.3661044772183232
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1,_FENRETINIDE,PERIPHERAL T CELL LYMPHOMA,NCT02495415,Phase 2,0.8656528218293892,0.1343471781706107
COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C,_TASQUINIMOD,MULTIPLE MYELOMA,NCT04405167,Phase 1,0.7984332390177972,0.2015667609822028
CC[C@H](Nc1ncnc2[nH]cnc12)c1oc2ccccc2c(=O)c1-c1cccc(F)c1,_TENALISIB,HEMATOLOGICAL MALIGNANCY,NCT03711604,Phase 1|Phase 2,0.7233969727140276,0.2766030272859724
CC[C@H](Nc1ncnc2[nH]cnc12)c1oc2ccccc2c(=O)c1-c1cccc(F)c1,_TENALISIB,"LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL",NCT04204057,Phase 2,0.7233969727140276,0.2766030272859724
CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,_SELICICLIB,CUSHING DISEASE,NCT03774446,Phase 2,0.7455971232257417,0.2544028767742583
COc1cc(C(=O)c2c(C)oc3c(OP(=O)(O)O)c(OC)ccc23)cc(OC)c1OC,_BNC105,CHRONIC LYMPHOCYTIC LEUKEMIA,NCT03454165,Phase 1,0.7394752873245036,0.2605247126754964
Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,_ENZASTAURIN,DIFFUSE LARGE B-CELL LYMPHOMA,NCT03263026,Phase 3,0.702604076625967,0.29739592337403303
Cl.Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,_ENZASTAURIN_HYDROCHLORIDE,DIFFUSE LARGE B-CELL LYMPHOMA,NCT03263026,Phase 3,0.5849407795642978,0.4150592204357022
C[N@+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_METHYLNALTREXONE,PANCREATIC CANCER,NCT04083651,Phase 2|Phase 3,0.4556675937415753,0.5443324062584247
CC(=O)N[C@@H]1C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC2[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]2NC(C)=O)[C@H](O)[C@H]1O,_HYALURONIC_ACID,"PAIN, POSTOPERATIVE",NCT03814707,Not Applicable,0.1079620094755456,0.8920379905244544
O=[O+][O-],_OZONE,ISCHEMIC HEART DISEASE,NCT03660657,Phase 2|Phase 3,0.29309203392698585,0.7069079660730142
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,_FLUTICASONE_FUROATE,PHARMACOKINETICS,NCT03739294,Phase 2,0.2609309181633933,0.7390690818366066
Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,_CANAGLIFLOZIN,HEART FAILURE,NCT04252287,Phase 3,0.6410901514656551,0.3589098485343451
C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1,_POZIOTINIB,NSCLC,NCT04402008,Phase 1|Phase 2,0.576125319166542,0.4238746808334581
O=C(O)c1cc(O)c2c(c1)C(C1c3cc(C(=O)O)cc(O)c3C(=O)c3c(OC4OC(CO)C(O)C(O)C4O)cccc31)c1cccc(OC3OC(CO)C(O)C(O)C3O)c1C2=O,_SENNOSIDES,COLON CANCER,NCT03475680,Phase 3,0.3799955414806388,0.6200044585193611
Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,_BRIVANIB,OVARIAN CANCER,NCT03895788,Phase 1,0.5327927667384575,0.4672072332615425
CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,_SARACATINIB,PARKINSON DISEASE PSYCHOSIS,NCT03661125,Early Phase 1,0.7750234492019038,0.2249765507980962
C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(=O)O,_DOTATATE,NEUROENDOCRINE TUMORS,NCT04318561,Phase 1|Phase 2,0.2380770301424997,0.7619229698575005
C[S@@](=O)CCCCN=C=S,_SULFORAPHANE,DEPRESSION,NCT04246905,Phase 2,0.18210873050241744,0.8178912694975824
C[S@@](=O)CCCCN=C=S,_SULFORAPHANE,LUNG CANCER,NCT03232138,Phase 2,0.5662587398033075,0.4337412601966924
O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1,_PIMONIDAZOLE,PROSTATE CANCER,NCT02095249,Not Applicable,0.7024873006356755,0.29751269936432473
O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1,_PIMONIDAZOLE,HEAD AND NECK CANCER,NCT02414048,Phase 2,0.7057334637812168,0.2942665362187834
CC(=O)N[C@H](CSSC[C@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O,_ETELCALCETIDE,END STAGE RENAL DISEASE,NCT03795558,Phase 2,0.6473333558927399,0.3526666441072602
CC(=O)N[C@H](CSSC[C@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O,_ETELCALCETIDE,SECONDARY HYPERPARATHYROIDISM|CHRONIC KIDNEY DISEASE,NCT03633708,Phase 3,0.5808687104443017,0.4191312895556985
CCCCCCCCCCCCCCCC(=O)NCC(O)COP(=O)(S)OCC1OC(n2cc(C)c(=O)[nH]c2=O)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(=O)[nH]c(N)nc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(=O)[nH]c(N)nc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(=O)[nH]c(N)nc32)CC1NP(=O)(S)OCC1OC(n2cc(C)c(=O)[nH]c2=O)CC1NP(=O)(S)OCC1OC(n2cc(C)c(=O)[nH]c2=O)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(=O)[nH]c(N)nc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1NP(=O)(S)OCC1OC(n2ccc(N)nc2=O)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1NP(=O)(S)OCC1OC(n2cnc3c(N)ncnc32)CC1N,_IMETELSTAT,MYELODYSPLASTIC SYNDROME,NCT02598661,Phase 2|Phase 3,0.7483212218857386,0.25167877811426154
C[C@]1([18F])C[C@@](N)(C(=O)O)C1,_FLUCICLOVINE_F18,PROSTATE ADENOCARCINOMA,NCT03762759,Phase 2,0.4351632417416067,0.5648367582583933
C[C@]1([18F])C[C@@](N)(C(=O)O)C1,_FLUCICLOVINE_F18,GLIOBLASTOMA,NCT03926507,Early Phase 1,0.2853697430010548,0.7146302569989451
CN1CCN(C(=O)C2C(C(=O)O)[C@H]3CC[C@@H]2O3)CC1,_LB-100,MYELODYSPLASTIC SYNDROME,NCT03886662,Phase 1|Phase 2,0.8768526814197037,0.12314731858029646
O=C1/C(=C2\Nc3ccccc3C2=O)Nc2ccccc21,_INDIGO,COLONOSCOPY,NCT03250780,Not Applicable,0.5929929488566215,0.4070070511433788
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](C(N)=O)C(C)C,_SECRETIN,PANCREATIC CANCER,NCT03404661,,0.8835123375727878,0.11648766242721198
NC(=O)OCC(COC(N)=O)c1ccccc1,_FELBAMATE,EPILEPSY,NCT03196466,,0.31174816958020257,0.6882518304197974
O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,_DANTROLENE,MULTIPLE SCLEROSIS,NCT03109288,Phase 1|Phase 2,0.6491040198197799,0.35089598018021995
N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl,_TIPIRACIL,COLORECTAL CANCER,NCT03974594,Phase 1,0.3851931726554593,0.6148068273445406
COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,_ENCORAFENIB,NON SMALL CELL LUNG CANCER,NCT03915951,Phase 2,0.5696812567090842,0.4303187432909159
CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1,_LASMIDITAN,MIGRAINE DISORDERS,NCT04396574,Phase 3,0.4219985914922774,0.5780014085077224
Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,_ALPELISIB,BREAST CANCER,NCT03056755,Phase 2,0.6168118795811611,0.3831881204188389
Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,_ALPELISIB,MENINGIOMA,NCT03631953,Phase 1,0.4679449696194082,0.5320550303805917
COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,_ERDAFITINIB,METASTATIC BREAST CANCER,NCT03238196,Phase 1,0.7790570000521063,0.22094299994789332
COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,_ERDAFITINIB,RELAPSED REFRACTORY MULTIPLE MYELOMA,NCT03732703,Phase 1|Phase 2,0.6894999174560544,0.31050008254394545
CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,_DAROLUTAMIDE,PROSTATE CANCER,NCT04136353,Phase 3,0.4926814145831723,0.5073185854168277
CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,_DAROLUTAMIDE,METASTATIC CASTRATION-RESISTANT PROSTATE CANCER,NCT04237584,Phase 3,0.6163417500908338,0.3836582499091664
CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,_ENASIDENIB,ACUTE MYELOID LEUKEMIA,NCT04075747,Phase 1,0.6987364944883021,0.30126350551169795
CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,_ENASIDENIB,RELAPSED REFRACTORY MULTIPLE MYELOMA,NCT03732703,Phase 1|Phase 2,0.7057472617733914,0.2942527382266086
C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,_ZANUBRUTINIB,DIFFUSE LARGE B CELL LYMPHOMA,NCT04460248,Phase 2,0.3262124058725105,0.6737875941274895
C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,_ZANUBRUTINIB,WALDENSTRÃ–M MACROGLOBULINEMIA,NCT04463953,Phase 2,0.3520315192471161,0.6479684807528838
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,SPONDYLOARTHRITIS,NCT04169373,Phase 3,0.5834459205334372,0.4165540794665627
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,ULCERATIVE COLITIS,NCT03006068,Phase 3,0.5601086333896084,0.4398913666103916
C[C@@H]1[C@H](c2ccccc2)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F,_UBROGEPANT,MIGRAINE DISORDERS,NCT04492020,Phase 3,0.5901631044662675,0.4098368955337325
